<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Roelandt, J.R.T.C.</title>
    <link>http://repub.eur.nl/res/aut/792/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Recommendations of the European Association of Echocardiography How to use echo-Doppler in clinical trials: Different modalities for different purposes (Article)</title>
      <link>http://repub.eur.nl/res/pub/26385/</link>
      <pubDate>2011-05-01T00:00:00Z</pubDate>
      <description>The European Association of Echocardiography (EAE) has developed the present recommendations to assist clinical researchers in the design, implementation, and conduction of echocardiographic protocols for clinical trials and to guarantee their quality. Clinical trials should be designed and conducted based on the knowledge of the pathophysiology of the clinical condition studied, the technical characteristics of the echo-Doppler modalities, and the variability of the tested parameters. These procedures are important to choose the most reliable and reproducible techniques and parameters. Quality assurance must be guaranteed by adequate training of peripheral site operators to obtain optimal echo-Doppler data and by using a core laboratory for accurate and reproducible data analysis. </description>
    </item> <item>
      <title>Recommendations for transoesophageal echocardiography: Update 2010 (Article)</title>
      <link>http://repub.eur.nl/res/pub/21051/</link>
      <pubDate>2010-08-01T00:00:00Z</pubDate>
      <description>Transoesophageal echocardiography (TOE) is a standard and indispensable technique in clinical practice. The present recommendations represent an update and extension of the recommendations published in 2001 by the Working Group on Echocardiography of the European Society of Cardiology. New developments covered include technical advances such as 3D transoesophageal echo as well as developing applications such as transoesophageal echo in aortic valve repair and in valvular interventions, as well as a full section on perioperative TOE.</description>
    </item> <item>
      <title>European association of echocardiography recommendations for the assessment of valvular regurgitation. Part 2: Mitral and tricuspid regurgitation (native valve disease) (Article)</title>
      <link>http://repub.eur.nl/res/pub/28539/</link>
      <pubDate>2010-05-01T00:00:00Z</pubDate>
      <description>Mitral and tricuspid are increasingly prevalent. Doppler echocardiography not only detects the presence of regurgitation but also permits to understand mechanisms of regurgitation, quantification of its severity and repercussions. The present document aims to provide standards for the assessment of mitral and tricuspid regurgitation. </description>
    </item> <item>
      <title>European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: Aortic and pulmonary regurgitation (native valve disease) (Article)</title>
      <link>http://repub.eur.nl/res/pub/28563/</link>
      <pubDate>2010-04-01T00:00:00Z</pubDate>
      <description>Valvular regurgitation represents an important cause of cardiovascular morbidity and mortality. Echocardiography has become the primary non-invasive imaging method for the evaluation of valvular regurgitation. The echocardiographic assessment of valvular regurgitation should integrate quantification of the regurgitation, assessment of the valve anatomy, and function as well as the consequences of valvular disease on cardiac chambers. In clinical practice, the management of patients with valvular regurgitation thus largely integrates the results of echocardiography. It is crucial to provide standards that aim at establishing a baseline list of measurements to be performed when assessing regurgitation. </description>
    </item> <item>
      <title>Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters: A feasibility study (Article)</title>
      <link>http://repub.eur.nl/res/pub/28700/</link>
      <pubDate>2010-03-01T00:00:00Z</pubDate>
      <description>Objectives: The aim of this study was to investigate the feasibility of using quantitative differential echogenicity to monitor the in vivo absorption process of a drug-eluting poly-l-lactic-acid (PLLA) bioabsorbable stent (BVS, Abbott Vascular, Santa Clara, CA). Background: A new bioabsorbable, balloon-expanded coronary stent was recently evaluated in a first-in-man study. Little is known about the absorption process in vivo in diseased human coronary arteries. Methods: In the ABSORB (Clinical Evaluation of the BVS everolimus eluting stent system) study, 30 patients underwent treatment with the BVS coronary stent system and were examined with intracoronary ultrasound (ICUS) after implantation, at 6 months and at 2-year follow-up. Quantitative ICUS was used to measure dimensional changes, and automated ICUS-based tissue composition software (differential echogenicity) was used to quantify plaque compositional changes over time in the treated regions. Results: The BVS struts appeared as bright hyperechogenic structures and showed a continuous decrease of their echogenicity over time, most likely due to the polymer degradation process. In 12 patients in whom pre-implantation ICUS was available, at 2 years the percentage-hyperechogenic tissue was close to pre-implantation values, indicating that the absorption process was either completed or the remaining material was no longer differentially echogenic from surrounding tissues. Conclusions: Quantitative differential echogenicity is a useful plaque compositional measurement tool. Furthermore, it seems to be valuable for monitoring the absorption process of bioabsorbable coronary stents made of semi-crystalline polymers. </description>
    </item> <item>
      <title>European Association of Echocardiography recommendations for training, competence, and quality improvement in echocardiography (Article)</title>
      <link>http://repub.eur.nl/res/pub/27088/</link>
      <pubDate>2009-12-01T00:00:00Z</pubDate>
      <description>The main mission statement of the European Association of Echocardiography (EAE) is 'to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular ultrasound in Europe'. As competence and quality control issues are increasingly recognized by patients, physicians, and payers, the EAE has established recommendations for training, competence, and quality improvement in echocardiography. The purpose of this document is to provide the requirements for training and competence in echocardiography, to outline the principles of quality measurement, and to recommend a set of measures for improvement, with the ultimate goal of raising the standards of echocardiographic practice in Europe.</description>
    </item> <item>
      <title>Coronary calcium significantly affects quantitative analysis of coronary ultrasound: Importance for atherosclerosis progression/regression studies (Article)</title>
      <link>http://repub.eur.nl/res/pub/24726/</link>
      <pubDate>2009-09-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Coronary atherosclerosis is a dynamic process, which progresses differently in coronary segments containing noncalcified or calcified plaques. This may have implications for the study of the effects of therapy on progression/regression. OBJECTIVE: To test this hypothesis, we performed a post-hoc analysis on data of a randomized trial in which perindopril treatment was compared with placebo on progression/regression of atherosclerosis with regard to the degree of calcification. METHODS AND RESULTS: The intracoronary ultrasound data of 118 patients, who were enrolled in the multicentre, double-blinded randomized trial (PERSPECTIVE), were analysed. Vessel, lumen and plaque areas were measured in 711 5-mm-long matched coronary segments (perindopril 360, placebo 351). Each individual intracoronary ultrasound cross-section was binary labelled for the presence of calcium (yes/no), and the degree of calcium was assessed as a percentage of length. The segments were classified into three groups: 0-25, 25-50 and 50-100% (percentage of length) calcification. Coronary plaques with no or little calcium (0-25%) regressed on perindopril and did not change on placebo (-0.33±1.74 vs. -0.03±1.66, respectively; P=0.04). Plaques containing moderate calcium (group 25-50%) did not change and plaques with severe amounts of calcification (group 50-100%) equally progressed. CONCLUSION: Noncalcified plaques may be amenable to regression with ACE inhibitor treatment. The method, which considers the amount of calcium content in a plaque, may lead to new insights for quantitative analysis of the effects of therapy in progression/regression studies of atherosclerosis. </description>
    </item> <item>
      <title>Prognosis of patients with ischaemic cardiomyopathy after coronary revascularisation: Relation to viability and improvement in left ventricular ejection fraction (Article)</title>
      <link>http://repub.eur.nl/res/pub/24894/</link>
      <pubDate>2009-08-01T00:00:00Z</pubDate>
      <description>Background: In patients with ischaemic cardiomyopathy and viable myocardium, left ventricular ejection fraction (LVEF) does not always improve after revascularisation. Whether this may affect prognosis is unclear. Objective: To evaluate the prognosis of viable patients with and without improvement of LVEF after coronary revascularisation. Methods: Before revascularisation, radionuclide ventriculography (RNV) and dobutamine stress echocardiography were performed to assess LVEF and myocardial viability, respectively. Nine to 12 months after revascularisation, LVEF improvement was assessed by RNV. Patients were divided into three groups: group 1, viable patients with LVEF improvement (n=27); group 2, viable patients without LVEF improvement (n=15), group 3, non-viable patients (n=48). Cardiac events were evaluated during a 4-year follow-up. Results: After revascularisation, the mean (SD) LVEF improved from 32 (9)% to 42 (10)% in group 1, but did not change significantly in group 2 and in group 3, p&lt;0.001 by analysis of variance (ANOVA). Heart failure symptoms improved in both groups 1 (mean (SD) NYHA class from 3.1 (0.9) to 1.7 (0.7)) and 2 (from 3.2 (0.7) to 1.7 (0.9)), but not in group 3 (from 2.8 (1.0) to 2.7 (0.5)), p&lt;0.001 by ANOVA. During follow-up, the cardiac event rate was low (4%) in group 1, intermediate (21%) in group 2 and high (33%) in group 3 (p=0.01). Conclusion: The best prognosis after revascularisation may be expected in those viable patients whose LVEF improves. Conversely, viable patients without functional improvement have an intermediate prognosis.</description>
    </item> <item>
      <title>Comparison Between Tissue Doppler Imaging and Velocity-Encoded Magnetic Resonance Imaging for Measurement of Myocardial Velocities, Assessment of Left Ventricular Dyssynchrony, and Estimation of Left Ventricular Filling Pressures in Patients With Ischemic Cardiomyopathy (Article)</title>
      <link>http://repub.eur.nl/res/pub/29025/</link>
      <pubDate>2008-11-15T00:00:00Z</pubDate>
      <description>Velocity-encoded magnetic resonance imaging (VE-MRI), commonly used to perform flow measurements, can be applied for myocardial velocity analysis, similar to tissue Doppler imaging (TDI). In this study, a comparison between VE-MRI and TDI was performed for the assessment of left ventricular dyssynchrony and left ventricular filling pressures. Ten healthy volunteers and 22 patients with heart failure secondary to ischemic cardiomyopathy underwent both VE-MRI and TDI. Longitudinal myocardial peak systolic and diastolic velocities and time to peak systolic velocity (Ts) were measured with both techniques at the level of left ventricular septum and lateral wall. To quantify left ventricular dyssynchrony, the delay in Ts between basal septum and lateral wall was calculated (SLD) and patients were categorized into 3 groups: minimal (SLD &lt;30 ms), intermediate (SLD = 30 to 60 ms) and extensive (SLD &gt;60 ms) left ventricular dyssynchrony. The ratio of transmitral E wave velocity and mitral annulus septal early velocity (E/E' ratio) was also assessed, and patients were divided into 3 groups: normal (E/E' &lt;8), probably abnormal (E/E' = 8 to 15), and elevated (E/E' &gt;15) left ventricular filling pressures. Excellent correlations were observed for peak systolic velocity and peak diastolic velocity (r = 0.95, p &lt;0.001) measured with TDI and VE-MRI. A small bias (p &lt;0.001) of -1.1 ± 1.1 cm/s for peak systolic velocity and of -0.45 ± 1.03 cm/s for peak diastolic velocity was noted between the 2 techniques. A strong correlation was also noted between Ts measured with TDI and VE-MRI (r = 0.97, p &lt;0.001) without a significant difference. TDI and VE-MRI showed an excellent agreement for left ventricular dyssynchrony and left ventricular filling pressures classification with a weighted κ of 0.96 and 0.91, respectively. In conclusion, TDI and VE-MRI are highly concordant and can be used interchangeably for the assessment of left ventricular dyssynchrony and filling pressures. </description>
    </item> <item>
      <title>Contrast-enhanced three-dimensional dobutamine stress echocardiography: Between Scylla and Charybdis? (Article)</title>
      <link>http://repub.eur.nl/res/pub/30426/</link>
      <pubDate>2008-11-01T00:00:00Z</pubDate>
      <description>Aims: Real-time three-dimensional echocardiography (RT3DE) allows quick volumetric scanning of the left ventricle (LV). We evaluated the diagnostic accuracy of contrast-enhanced stress RT3DE for the detection of coronary artery disease (CAD) in comparison with coronary arteriography as the reference technique. Methods and results: Forty-five consecutive patients (age 59 ± 10, 31 males) referred for coronary angiography were examined by contrast-enhanced RT3DE. Wall motion analysis was performed off-line by dedicated software. New or worsening wall motion abnormalities were detected in 17 of 28 patients with significant CAD (sensitivity 61%), and in two of 17 patients without significant CAD (specificity 88%). The sensitivity for detection of single-vessel CAD was 8/15 patients (53%), for two-vessel CAD 4/6 (67%), and for three-vessel CAD 5/7 (71%). In 35 patients, comparison with conventional RT3DE was available. The image quality index at rest improved from 2.5 ± 1.2 to 3.2 ± 1.0 (P &lt; 0.001) with contrast and at peak stress from 2.3 ± 1.2 to 3.1 ± 1.0 (P &lt; 0.001). Interobserver agreement on the diagnosis of myocardial ischaemia improved from 26 of 35 studies (74%, κ = 0.44) with conventional stress RT3DE to 30 of 35 studies (86%, κ = 0.69) with contrast-enhanced stress RT3DE. Sensitivity increased from 50 to 55% and specificity from 69 to 85% with contrast-enhanced stress RT3DE in this subset of patients. Conclusion: Despite some important practical and theoretical benefits, contrast-enhanced stress RT3DE currently has only moderate diagnostic sensitivity due to several technical limitations as temporal and spatial resolution. </description>
    </item> <item>
      <title>Technological advances in tissue Doppler imaging echocardiography (Article)</title>
      <link>http://repub.eur.nl/res/pub/30285/</link>
      <pubDate>2008-08-01T00:00:00Z</pubDate>
      <description>Tissue Doppler imaging is a recently introduced echocardiographic tool for measuring myocardial velocities. In this article the physical principles and different myocardial velocity imaging modalities are discussed. Examples of practical applications and clinical use of this non-invasive imaging technique are provided.</description>
    </item> <item>
      <title>Partial ventricular septal defect (Pacman® Heart) (Article)</title>
      <link>http://repub.eur.nl/res/pub/30418/</link>
      <pubDate>2008-03-01T00:00:00Z</pubDate>
      <description>Complete ventricular septal defects (VSD) can be congenital (estimated prevalence 0.5% in live births) (Roguin N, et al. High prevalence of muscular ventricular septal defect in neonates. J Am Coll Cardiol 1995;26:1545-1548) or may be a complication of acute myocardial infarction (estimated incidence in the era of thrombolysis 0.2%) [Crenshaw BS, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation 2000;101:27-32]. In this paper, we report two unique cases of partial VSD. </description>
    </item> <item>
      <title>Three-dimensional and quantitative analysis of atherosclerotic plaque composition by automated differential echogenicity (Article)</title>
      <link>http://repub.eur.nl/res/pub/36954/</link>
      <pubDate>2007-12-01T00:00:00Z</pubDate>
      <description>Objective: To validate automated and quantitative three-dimensional analysis of coronary plaque composition using intracoronary ultrasound (ICUS). Background: ICUS displays different tissue components based on their acoustic properties in 256 grey-levels. We hypothesised that computer-assisted image analysis (differential echogenicity) would permit automated quantification of several tissue components in atherosclerotic plaques. Methods and Results: Ten 40-mm-long left anterior descending specimens were excised during autopsy of which eight could be successfully imaged by ICUS. Histological sections were taken at 5 mm intervals and analyzed. Since most of the plaques were calcified and having a homogeneous appearance, one specimen with a more heterogeneous composition was further examined: at each interval of 5 mm, 15 additional sections (every 100 μm) were evaluated. Plaques were scored for echogenicity against the adventitia: brighter (hyperechogenic) or less bright (hypoechogenic). Areas of hypoechogenicity correlated with the presence of smooth muscle cells. Areas of hyperechogenicity correlated with presence of collagen, and areas of hyperechogenicity with acoustic shadowing correlated with calcium. None of these comparisons showed statistical significant differences. Conclusion: This ex vivo feasibility study shows that automated three-dimensional differential echogenicity analysis of ICUS images allows identification of different tissue types within atherosclerotic plaques. This technology may play a role as an additional tool in longitudinal studies to trace possible changes in plaque composition. </description>
    </item> <item>
      <title>Comparison of Contrast Agent-Enhanced Versus Non-Contrast Agent-Enhanced Real-Time Three-Dimensional Echocardiography for Analysis of Left Ventricular Systolic Function (Article)</title>
      <link>http://repub.eur.nl/res/pub/35112/</link>
      <pubDate>2007-11-01T00:00:00Z</pubDate>
      <description>Ultrasound contrast has shown to improve endocardial border definition. The purpose of this study was to evaluate the value of contrast agent-enhanced versus non-contrast agent-enhanced real-time 3-dimensional echocardiography (RT3DE) for the assessment of left ventricular (LV) volumes and ejection fraction. Thirty-nine unselected patients underwent RT3DE with and without SonoVue contrast agent enhancement and magnetic resonance imaging (MRI) on the same day. An image quality index was calculated by grading all 16 individual LV segments on a scale of 0 to 4: 0, not visible; 1, poor; 2, moderate; 3, good; and 4, excellent. The 3-dimensional data sets were analyzed offline using dedicated TomTec analysis software. By manual tracing, LV end-systolic volume, LV end-diastolic volume, and LV ejection fraction were calculated. After contrast agent enhancement, mean image quality index improved from 2.4 ± 1.0 to 3.0 ± 0.9 (p &lt;0.001). Contrast agent-enhanced RT3DE measurements showed better correlation with MRI (LV end-diastolic volume, r = 0.97 vs 0.86; LV end-systolic volume, r = 0.96 vs 0.94; LV ejection fraction, r = 0.94 vs 0.81). The limits of agreement (Bland-Altman analysis) showed a similar bias for RT3DE images with and without contrast agent but with smaller limits of agreement for contrast agent-enhanced RT3DE. Also, inter- and intraobserver variabilities decreased. In a subgroup, patients with poor to moderate image quality showed an improvement in agreement after administration of contrast agent (±24.4% to ±12.7%) to the same level as patients with moderate to good image quality without contrast agent (±10.4%). In conclusion, contrast agent-enhanced RT3DE is more accurate in assessment of LV function as evidenced by better correlation and narrower limits of agreement compared with MRI, as well as lower intra- and interobserver variabilities. </description>
    </item> <item>
      <title>Real-time 3-Dimensional Contrast Stress Echocardiography: A Bridge Too Far? (Article)</title>
      <link>http://repub.eur.nl/res/pub/36251/</link>
      <pubDate>2007-10-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Three-dimensional echocardiographic analysis of left ventricular function during hemodialysis (Article)</title>
      <link>http://repub.eur.nl/res/pub/37078/</link>
      <pubDate>2007-10-01T00:00:00Z</pubDate>
      <description>Background: The effects of hemodialysis (HD) on left ventricular (LV) function have been studied by various echocardiographic techniques (M-mode, 2D echocardiography). These studies are hampered by a low accuracy of measurements because of geometric assumptions regarding LV shape. Three-dimensional echocardiography (3DE) overcomes this limitation. Methods: We tested the feasibility of 3DE assessment of LV function during HD. Conventional biplane Simpson rule (BSR) and single plane area length method (SPM) for LV function analysis were used as a reference. Results: 12 HD patients were studied and in 10 (83%) a total of 80 3D datasets were acquired. In 3 patients, one dataset (4%) was of insufficient quality and excluded from analysis. Correlation between SPM, BSR and 3DE for calculation of end-diastolic (EDV, r = 0.89 and r = 0.92, respectively), end-systolic volume (ESV, r = 0.92 and r = 0.93, respectively) and for ejection fraction (EF, r = 0.90 and r = 0.88, respectively) was moderate. Limits-of-agreement results for EDV and ESV were poor with confidence intervals larger than 30 ml. Both 2DE methods underestimated end-diastolic and end-systolic volume, while overestimating ejection fraction. Conclusion: 3DE is feasible for image acquisition during HD, which opens the possibility for accurate and reproducible measurement of LV function during HD. This may improve the assessment of the acute effect of HD on LV performance, and guide therapeutic strategies aimed at preventing intradialytic hypotension. Copyright </description>
    </item> <item>
      <title>Can echocardiographic findings predict falls in older persons? (Article)</title>
      <link>http://repub.eur.nl/res/pub/37143/</link>
      <pubDate>2007-07-25T00:00:00Z</pubDate>
      <description>Background. The European and American guidelines state the need for echocardiography in patients with syncope. 50% of older adults with syncope present with a fall. Nonetheless, up to now no data have been published addressing echocardiographic abnormalities in older fallers. Method and Findings. In order to determine the association between echocardiographic abnormalities and falls in older adults, we performed a prospective cohort study, in which 215 new consecutive referrals (age 77.4 SD 6.0) of a geriatric outpatient clinic of a Dutch university hospital were included. During the previous year, 139 had experienced a fall. At baseline, all patients underwent routine two-dimensional and Doppler echocardiography. Falls were recorded during a three-month follow-up. Multivariate adjustment for compounders was performed with a Cox proportional hazards model. 557 patients (26%) fell at least once during follow-up. The adjusted hazard ratio of a fall during follow-up was 135 (95% Cl, 1.08-1.71) for pulmonary hypertension, 1.66 (95% Cl, 1.01 to 2.89) for 4-initial regurgitation, 2.41 (95% Cl, 1.32 to 4.37) for tricuspid regurgitation and 1.76 (95% Cl, 1.03 to 3.01) for pulmonary regurgitation. For aoitic regurgitation the risk of a fall was also increased, but non-significantly. (hazard ratio, 1.57 [95% Cl 0.85 to 2.92]). Trend analysis of the severity of the difterent regurgitations showed a significant relationship for mitral, tricuspid and pulmonary valve regurgitation and pulmonary hypertension. Conclusions. Echo(Dopler)cardiography can be useful in order to identify risk indicators for falling. Presence of pulmonary hypertension or regurgitation of mitral, tricuspid or pulmonary valves was associated with a higher fall risk. Our study indicates that the diagnostic work-up for falls in older adults might be improved by adding an echo(Doppler)cardiogram in selected groups. </description>
    </item> <item>
      <title>Reproducible coronary plaque quantification by multislice computed tomography (Article)</title>
      <link>http://repub.eur.nl/res/pub/37022/</link>
      <pubDate>2007-05-01T00:00:00Z</pubDate>
      <description>Background: The aim of this study was to investigate reproducibility end accuracy of computer-assisted coronary plaque measurements by multislice computed tomography coronary angiography (QMSCT-CA). Methods and Results: Forty-sight patients undergoing MSCT-CA end coronary arteriography for symptomatic coronary artery disease and quantitative intravascular ultrasound (IVUS, QCU) were examined. Two investigators performed the QMSCT-CA twice end e third investigator performed the QCU, all blinded for each other's results. There was no difference found for the matched region of interest (ROI) lengths (QCU 29.4 ± 13 mm vs. QMSCT-CA 29.6 ± 13 mm, P = 0.6; total length = 1,400 mm). The comparison of volumetric measurements showed (lumen QCU 267 ± 139 mm3vs. mean QMSCT-CA 177 ± 91 mm3, P &lt; 0.001; vessel 454 ± 194 mm3vs. 398 ± 187 mm3, P &lt; 0.001; and plaque 189 ± 93 mm3vs. 222 ± 121 mm3; investigator 1, P = 0.02; and investigator 2, P = 0.07) significant differences. Automated lumen detection was also applied for QMSCT-CA (218 ± 112 mm3, P &lt; 0.001 vs. QCU). The Interinvestigator variability measurements for QMSCT-CA showed no significant differences. Conclusion: QMSCT-CA systematically underestimates absolute coronary lumen- and vessel dimensions when compared with QCU. However, repeated measurements of coronary plaque by QMSCT-CA showed no statistically significant differences, although, the outcome showed a scattered result. Automated lumen detection for QMSCT-CA showed improved results when compered with those of human investigators. </description>
    </item> <item>
      <title>Efficient Quantification of the Left Ventricular Volume Using 3-Dimensional Echocardiography: The Minimal Number of Equiangular Long-axis Images for Accurate Quantification of the Left Ventricular Volume (Article)</title>
      <link>http://repub.eur.nl/res/pub/36302/</link>
      <pubDate>2007-04-01T00:00:00Z</pubDate>
      <description>For quantification of the left ventricular volume from 3-dimensional echocardiograms a number of cross-sectional images are used. The goal of this study was to determine the minimum number of long-axis images necessary for accurate quantification of the left ventricular volume. A strong correlation was observed between volumes obtained from magnetic resonance imaging and 3-dimensional echocardiography using 16 equiangular images (r = 0.99; y = 0.95x + 3.3 mL; standard error of the estimate = 7.0 mL; N = 30). Comparison of these results with random subsets showed a significant difference for volumes obtained with 4 and 2 equiangular images (P &lt; .005). However, when the subsets were selected to target the eccentric region of the endocardial border this was only the case for subsets of two images (P &lt; .001). This study demonstrates that accurate left ventricular volume quantification can be performed with as little as 8 equiangular long-axis images. By selecting the correctly oriented image set, this number can even be brought down to 4, which will further reduce the analysis time. </description>
    </item> <item>
      <title>Three-Dimensional Echocardiographic Analysis of Left Ventricular Function during Hemodialysis (Article)</title>
      <link>http://repub.eur.nl/res/pub/10480/</link>
      <pubDate>2007-01-01T00:00:00Z</pubDate>
      <description>Background: The effects of hemodialysis (HD) on left ventricular (LV) function have been studied by various echocardiographic techniques (M-mode, 2D echocardiography). These studies are hampered by a low accuracy of measurements because of geometric assumptions regarding LV shape. Three-dimensional echocardiography (3DE) overcomes this limitation. Methods: We tested the feasibility of 3DE assessment of LV function during HD. Conventional biplane Simpson rule (BSR) and single plane area length method (SPM) for LV function analysis were used as a reference. Results: 12 HD patients were studied and in 10 (83%) a total of 80 3D datasets were acquired. In 3 patients, one dataset (4%) was of insufficient quality and excluded from analysis. Correlation between SPM, BSR and 3DE for calculation of end-diastolic (EDV, r = 0.89 and r = 0.92, respectively), end-systolic volume (ESV, r = 0.92 and r = 0.93, respectively) and for ejection fraction (EF, r = 0.90 and r = 0.88, respectively) was moderate. Limits-of-agreement results for EDV and ESV were poor with confidence intervals larger than 30 ml. Both 2DE methods underestimated end-diastolic and end-systolic volume, while overestimating ejection fraction. Conclusion: 3DE is feasible for image acquisition during HD, which opens the possibility for accurate and reproducible measurement of LV function during HD. This may improve the assessment of the acute effect of HD on LV performance, and guide therapeutic strategies aimed at preventing intradialytic hypotension.</description>
    </item> <item>
      <title>Evaluation of a hand carried cardiac ultrasound device in an outpatient cardiology clinic (Article)</title>
      <link>http://repub.eur.nl/res/pub/8319/</link>
      <pubDate>2005-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: To determine the diagnostic potential of a hand carried cardiac
      ultrasound (HCU) device (OptiGo, Philips Medical Systems) in a cardiology
      outpatient clinic and to compare the HCU diagnosis with the clinical
      diagnosis and diagnosis with a full featured standard echocardiography
      (SE) system. METHODS: 300 consecutive patients took part in the study. The
      HCU examination was performed by an experienced echocardiographer before
      patients visited the cardiologist. The echocardiographer noted whether the
      HCU device was able to confirm or reject the referral diagnosis, which
      abnormality was detected, and whether SE investigation was necessary.
      Physical examination by a cardiologist followed and thereafter, whenever
      required, a complete study with an SE was carried out. The HCU data were
      compared with the clinical diagnosis of the cardiologist and the SE
      diagnosis in a blinded manner. RESULTS: The cardiologist referred 203 of
      300 patients for an SE study and 13 patients for transoesophageal
      echocardiography. In 84 patients no further examination was considered
      necessary. HCU echocardiography was able to confirm or reject the
      suspected clinical diagnosis in 159 of 203 (78%) patients. In 44 of 203
      (22%) patients SE Doppler was needed. Agreement between the HCU device and
      the SE system for the detection of major abnormalities was excellent
      (98%). The HCU device missed 4% of the major findings. Among the 84
      patients not referred for an SE, the HCU device detected unsuspected major
      abnormalities missed with the physical examination in 14 (17%).
      CONCLUSION: Integration of an HCU device with the physical examination
      augments the yield of information.</description>
    </item> <item>
      <title>Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography (Article)</title>
      <link>http://repub.eur.nl/res/pub/8336/</link>
      <pubDate>2005-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVES: To compare the long term prognosis of patients having silent
      versus symptomatic ischaemia during dobutamine stress echocardiography
      (DSE). DESIGN: Observational study. SETTING: Tertiary referral centre.
      PATIENTS: 931 patients who experienced stress induced myocardial ischaemia
      during DSE. RESULTS: Silent ischaemia was present in 643 of 931 patients
      (69%). The number of dysfunctional segments at rest (mean (SD) 9.6 (5.1) v
      8.8 (5.0), p = 0.1) and of ischaemic segments (3.5 (2.2) v 3.8 (2.1), p =
      0.2) was comparable in both groups. During a mean (SD) follow up of 5.5
      (3.3) years, there were 169 (18%) cardiac deaths and 86 (9%) non-fatal
      infarctions. Multivariable Cox regression analysis showed age (hazard
      ratio (HR) 1.1, 95% confidence interval (CI) 1.02 to 1.05), previous
      myocardial infarction (HR 1.4, 95% CI 1.1 to 2.0), and number of ischaemic
      segments during the test (HR 2.0, 95% CI 1.0 to 3.7) as independent
      predictors of cardiac death and myocardial infarction. For every
      additional ischaemic segment there was a twofold increment in risk of late
      cardiac events. The annual cardiac death or myocardial infarction rate was
      3.0% in patients with symptomatic ischaemia and 4.6% in patients with
      silent ischaemia (p &lt; 0.01). Silent induced ischaemia was an independent
      predictor of cardiac death and myocardial infarction (HR 1.7, 95% CI 1.1
      to 2.0). During follow up symptomatic patients were treated more often
      with cardioprotective therapy (p &lt; 0.01) and coronary revascularisation
      (145 of 288 (50%) v 174 of 643 (27%), p &lt; 0.001). CONCLUSIONS: Patients
      with silent ischaemia had a similar extent of myocardial ischaemia during
      DSE compared to patients with symptomatic ischaemia but received less
      cardioprotective treatment and coronary revascularisation and experienced
      a higher cardiac event rate.</description>
    </item> <item>
      <title>Improvement of stress LVEF rather than rest LVEF after coronary revascularisation in patients with ischaemic cardiomyopathy and viable myocardium (Article)</title>
      <link>http://repub.eur.nl/res/pub/8344/</link>
      <pubDate>2005-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: To evaluate prospectively the response of left ventricular
      ejection fraction (LVEF) to high dose dobutamine infusion in patients
      showing substantial viability, with and without improved resting LVEF
      after revascularisation. METHODS: Before and 9-12 months after
      revascularisation, 50 patients with ischaemic cardiomyopathy (LVEF 32
      (8)%) and substantial myocardial viability (&gt; or = 4 viable segments)
      underwent radionuclide ventriculography and dobutamine stress
      echocardiography. Patients were divided into group 1, patients with, and
      group 2, patients without significant improvement in resting LVEF (&gt; or =
      5% by radionuclide ventriculography) after revascularisation. The response
      of LVEF during dobutamine stress echocardiography was compared in these
      two groups. RESULTS: Groups 1 and 2 were comparable in baseline
      characteristics, resting LVEF, and number of viable segments (mean (SD) 7
      (4) v 6 (2), not significant). After revascularisation, the LVEF response
      during dobutamine stress echocardiography improved significantly in both
      groups (group 1, 34 (10)% to 56 (8)%; group 2, 32 (10)% to 46 (11)%; both
      p &lt; 0.001). Interestingly, although resting LVEF did not improve in group
      2, peak stress LVEF after revascularisation did (p &lt; 0.001). Group 1
      patients had, however, a greater increase in peak stress LVEF (group 1, 22
      (10)%; group 2, 13 (9)%; p &lt; 0.01). New York Heart Association and
      Canadian Cardiovascular Society classes decreased in both groups.
      CONCLUSIONS: Although patients with viable myocardium did not always have
      improved rest LVEF after revascularisation, peak stress LVEF improved.
      Assessment of improvement of resting function may not be the ideal end
      point to evaluate successful revascularisation.</description>
    </item> <item>
      <title>Ablation lesions in Koch's triangle assessed by three-dimensional myocardial contrast echocardiography. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13596/</link>
      <pubDate>2004-12-09T00:00:00Z</pubDate>
      <description>BACKGROUND: Myocardial contrast echocardiography (MCE) allows
      visualization of radiofrequency (RF) ablation lesions in the left
      ventricle in an animal model. Aim: To test whether MCE allows
      visualization of RF and cryo ablation lesions in the human right atrium
      using three-dimensional echocardiography. METHODS: 18 patients underwent
      catheter ablation of a supraventricular tachycardia and were included in
      this prospective single-blind study. Twelve patients were ablated inside
      Koch's triangle and 6, who served as controls, outside this area.
      Three-dimensional echocardiography of Koch's triangle was performed before
      and after the ablation procedure in all patients, using respiration and
      ECG gated pullback of a 9 MHz ICE transducer, with and without continuous
      intravenous echocontrast infusion (SonoVue, Bracco). Two independent
      observers analyzed the data off-line. RESULTS: MCE identified ablation
      lesions as a low contrast area within the normal atrial myocardial tissue.
      Craters on the endocardial surface were seen in 10 (83%) patients after
      ablation. Lesions were identified in 11 out of 12 patients (92%). None of
      the control patients were recognized as having been ablated. The
      confidence score of the independent echo reviewer tended to be higher when
      the number of applications increased. CONCLUSIONS: 1. MCE allows direct
      visualization of ablation lesions in the human atrial myocardium. 2. Both
      RF and cryo energy lesions can be identified using MCE.</description>
    </item> <item>
      <title>Visualization of elusive structures using intracardiac echocardiography: insights from electrophysiology. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13459/</link>
      <pubDate>2004-07-14T00:00:00Z</pubDate>
      <description>Electrophysiological mapping and ablation techniques are increasingly used
      to diagnose and treat many types of supraventricular and ventricular
      tachycardias. These procedures require an intimate knowledge of
      intracardiac anatomy and their use has led to a renewed interest in
      visualization of specific structures. This has required collaborative
      efforts from imaging as well as electrophysiology experts. Classical
      imaging techniques may be unable to visualize structures involved in
      arrhythmia mechanisms and therapy. Novel methods, such as intracardiac
      echocardiography and three-dimensional echocardiography, have been refined
      and these technological improvements have opened new perspectives for more
      effective and accurate imaging during electrophysiology procedures.
      Concurrently, visualization of these structures noticeably improved our
      ability to identify intracardiac structures. The aim of this review is to
      provide electrophysiologists with an overview of recent insights into the
      structure of the heart obtained with intracardiac echocardiography and to
      indicate to the echo-specialist which structures are potentially important
      for the electrophysiologist.</description>
    </item> <item>
      <title>Adjustment method for mechanical Boston scientific corporation 30 MHz intravascular ultrasound catheters connected to a Clearview console. Mechanical 30 MHz IVUS catheter adjustment. (Article)</title>
      <link>http://repub.eur.nl/res/pub/4668/</link>
      <pubDate>2004-01-01T00:00:00Z</pubDate>
      <description>Intracoronary ultrasound (ICUS) is often used in studies evaluating new interventional techniques. It is important that quantitative measurements performed with various ICUS imaging equipment and materials are comparable. During evaluation of quantitative coronary ultrasound (QCU) software, it appeared that Boston Scientific Corporation (BSC) 30 MHz catheters connected to a Clearview ultrasound console showed smaller dimensions of an in vitro phantom model than expected. In cooperation with the manufacturer the cause of this underestimation was determined, which is described in this paper, and the QCU software was extended with an adjustment. Evaluation was performed by performing in vitro measurements on a phantom model consisting of four highly accurate steel rings (perfect reflectors) with diameters of 2, 3, 4 and 5 mm. Relative differences (unadjusted) of the phantom were respectively: 15.92, 13.01, 10.10 and 12.23%. After applying the adjustment: -0.96, -1.84, -1.35 and -1.43%. In vivo measurements were performed on 24 randomly selected ICUS studies. These showed differences for not adjusted vs. adjusted measurements of lumen-, vessel- and plaque volumes of -10.1 +/- 1.5, -6.7 +/- 0.9 and -4.4 +/- 0.6%. An off-line adjustment formula was derived and applied on previous numerical QCU output data showing relative differences for lumen- and vessel volumes of 0.36 +/- 0.51 and 0.13 +/- 0.31%. 30 MHz BSC catheters connected to a Clearview ultrasound console underestimate vessel dimensions. This can retrospectively be adjusted within QCU software as well as retrospectively on numerical QCU data using a mathematical model.</description>
    </item> <item>
      <title>Pulsed wave tissue Doppler imaging for the quantification of contractile reserve in stunned, hibernating, and scarred myocardium (Article)</title>
      <link>http://repub.eur.nl/res/pub/8302/</link>
      <pubDate>2004-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVES: To assess whether quantification of myocardial systolic
      velocities by pulsed wave tissue Doppler imaging can differentiate between
      stunned, hibernating, and scarred myocardium. DESIGN: Observational study.
      SETTING: Tertiary referral centre. PATIENTS: 70 patients with reduced left
      ventricular function caused by chronic coronary artery disease. METHODS:
      Pulsed wave tissue Doppler imaging was done close to the mitral annulus at
      rest and during low dose dobutamine; systolic ejection velocity (Vs) and
      the difference in Vs between low dose dobutamine and the resting value
      (DeltaVs) were assessed using a six segment model. Assessment of perfusion
      (with Tc-99m-tetrofosmin SPECT) and glucose utilisation (by
      18F-fluorodeoxyglucose SPECT) was used to classify dysfunctional regions
      (by resting cross sectional echocardiography) as stunned, hibernating, or
      scarred. RESULTS: 253 of 420 regions (60%) were dysfunctional. Of these,
      132 (52%) were classified as stunned, 25 (10%) as hibernating, and 96
      (38%) as scarred. At rest, Vs in stunned, hibernating, and scar tissue
      was, respectively, 6.3 (1.8), 6.6 (2.2), and 5.5 (1.5) cm/s (p = 0.001 by
      ANOVA). There was a gradual decline in Vs during low dose dobutamine
      infusion between stunned, hibernating, and scar tissue (8.3 (2.6) v 7.8
      (1.5) v 6.8 (1.9) cm/s, p &lt; 0.001 by ANOVA). DeltaVs was higher in stunned
      (2.1 (1.9) cm/s) than in hibernating (1.2 (1.4) cm/s, p &lt; 0.05) or scarred
      regions (1.3 (1.2) cm/s, p = 0.001). CONCLUSIONS: Quantitative tissue
      Doppler imaging showed a gradual reduction in regional velocities between
      stunned, hibernating, and scarred myocardium. Dobutamine induced
      contractile reserve was higher in stunned regions than in hibernating and
      scarred myocardium, reflecting different severities of myocardial damage</description>
    </item> <item>
      <title>Relation between left ventricular contractile reserve during low dose dobutamine echocardiography and plasma concentrations of natriuretic peptides (Article)</title>
      <link>http://repub.eur.nl/res/pub/8354/</link>
      <pubDate>2004-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: In ischaemic cardiomyopathy, raised plasma concentrations of
      natriuretic peptides are associated with a poor long term prognosis, while
      the presence of contractile reserve is a favourable sign. OBJECTIVE: To
      assess the relation between plasma natriuretic peptides and contractile
      reserve. DESIGN: Prospective observational study. SETTING: Tertiary
      referral centre. PATIENTS: 66 consecutive patients undergoing low dose
      dobutamine stress echocardiography to evaluate contractile reserve in
      regions with contractile dysfunction at rest, divided into two groups:
      group 1, 31 patients with ischaemic cardiomyopathy (left ventricular
      ejection fraction &lt; or = 40%) and heart failure symptoms; group 2, 35
      patients with normal left ventricular function. MAIN OUTCOME MEASURES:
      Plasma atrial natriuretic peptide (ANP) and brain natriuretic peptide
      (BNP), measured using immunoradiometric assays. Contractile reserve was
      defined as an improvement in segmental wall motion score during infusion
      of low dose dobutamine. RESULTS: Plasma ANP and BNP concentrations were
      higher in group 1 than in group 2 (mean (SD): ANP, 17.8 (32.8) v 7.2
      (9.7), p &lt; 0.005; BNP, 24.4 (69.0) v 5.0 (14.3) pmol/l, respectively; p &lt;
      0.001). In group 1, the presence of contractile reserve was inversely
      related to ANP and BNP levels; however, patients with contractile reserve
      had lower ANP and BNP concentrations than patients without contractile
      reserve (ANP, 14.2 (9.1) v 24.2 (44.2), p &lt; 0.05; BNP, 20.2 (25.5) v 37.5
      (93.8) pmol/l, respectively; p &lt; 0.05). CONCLUSIONS: Plasma natriuretic
      peptide concentrations are raised in patients with left ventricular
      dysfunction, but in the presence of preserved myocardial contractile
      reserve, relatively low levels of ANP and BNP are present.</description>
    </item> <item>
      <title>Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? (Article)</title>
      <link>http://repub.eur.nl/res/pub/10128/</link>
      <pubDate>2003-05-01T00:00:00Z</pubDate>
      <description>Stress echocardiography and myocardial perfusion imaging are commonly used noninvasive imaging modalities for the evaluation of ischaemic heart disease. Both modalities have proved clinically useful in the entire spectrum of coronary artery disease. Both techniques can detect coronary artery disease and provide prognostic information. Both techniques can identify low-risk and high-risk subsets among patients with known or suspected coronary artery disease and thus guide patient management decisions. In patients with acute myocardial infarction, both techniques have been used to identify residual viable tissue and predict improvement of function over time. In patients with chronic ischaemic left ventricular (LV) dysfunction, viability assessment with either modality can be used to predict improvement of function after revascularisation and thus guide patient treatment.</description>
    </item> <item>
      <title>Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13153/</link>
      <pubDate>2003-04-15T00:00:00Z</pubDate>
      <description>BACKGROUND: Patients undergoing major vascular surgery are at increased
      risk of perioperative mortality due to underlying coronary artery disease.
      Inhibitors of the 3-hydroxy-3-methylglutaryl coenzyme A (statins) may
      reduce perioperative mortality through the improvement of lipid profile,
      but also through the stabilization of coronary plaques on the vascular
      wall. METHODS AND RESULTS: To evaluate the association between statin use
      and perioperative mortality, we performed a case-controlled study among
      the 2816 patients who underwent major vascular surgery from 1991 to 2000
      at the Erasmus Medical Center. Case subjects were all 160 (5.8%) patients
      who died during the hospital stay after surgery. From the remaining
      patients, 2 controls were selected for each case and were stratified
      according to calendar year and type of surgery. For cases and controls,
      information was obtained regarding statin use before surgery, the presence
      of cardiac risk factors, and the use of other cardiovascular medication. A
      vascular complication during the perioperative phase was the primary cause
      of death in 104 (65%) case subjects. Statin therapy was significantly less
      common in cases than in controls (8% versus 25%; P&lt;0.001). The adjusted
      odds ratio for perioperative mortality among statin users as compared with
      nonusers was 0.22 (95% confidence interval 0.10 to 0.47). Similar results
      were obtained in subgroups of patients according to the use of
      cardiovascular therapy and the presence of cardiac risk factors.
      CONCLUSIONS: This case-controlled study provides evidence that statin use
      reduces perioperative mortality in patients undergoing major vascular
      surgery.</description>
    </item> <item>
      <title>Psychosocial functioning of the adult with congenital heart disease: a 20-33 years follow-up (Article)</title>
      <link>http://repub.eur.nl/res/pub/10117/</link>
      <pubDate>2003-04-01T00:00:00Z</pubDate>
      <description>AIMS: Since knowledge about the psychosocial function of adult patients
      with congenital heart disease is limited, we compared biographical
      characteristics, and emotional and social functioning of these patients
      with that of the reference groups. METHODS AND RESULTS: Patients with
      congenital heart disease (N=362, aged 20-46 years), belonging to five
      diagnostic groups, were subjected to extensive medical and psychological
      examination, 20-33 years after their first open heart surgery. All the
      patients were seen by the same psychologist, who examined their
      psychosocial functioning using a structured interview and questionnaires.
      The majority (78%)was living independently and showed favourable outcome
      regarding the marital status. Among married/cohabitant patients,
      25-39-year-olds showed normal offspring rates. None of the 20-24-year-old
      patients had any children. The offspring rate dropped after the age of 40.
      The proportion of adult patients with a history of special education was
      high (27%). Accordingly, patients showed lower educational and
      occupational levels compared to reference groups. As regard to the
      emotional and social functioning (leisure-time activities), the sample
      showed favourable results. CONCLUSIONS: Overall, this sample of patients
      with congenital heart disease seemed capable of leading normal lives and
      seemed motivated to make good use of their abilities.</description>
    </item> <item>
      <title>Dynamic Three-Dimensional Echocardiography Offers Advantages for Specific Site Pacing (Article)</title>
      <link>http://repub.eur.nl/res/pub/10089/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>We have developed a novel technique for specific site pacing.</description>
    </item> <item>
      <title>Prognostic value of dobutamine stress echocardiography in patients with diabetes (Article)</title>
      <link>http://repub.eur.nl/res/pub/10119/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: The aim of this study was to assess the incremental value of
      dobutamine stress echocardiography (DSE) for the risk stratification of
      diabetic patients who are unable to perform an adequate exercise stress
      test. Exercise capacity is frequently impaired in patients with diabetes.
      The role of pharmacologic stress echocardiography in the risk
      stratification of diabetic patients has not been well defined. RESEARCH
      DESIGN AND METHODS: We studied 396 diabetic patients (mean age 61 +/- 11
      years, 252 men [64%]) with limited exercise capacity who underwent DSE for
      evaluation of known or suspected coronary artery disease (CAD). End points
      were hard cardiac events (cardiac death and nonfatal myocardial
      infarction) and all causes of mortality. RESULTS: During a median
      follow-up of 3 years, 97 patients (24%) died (55 cardiac deaths), and 27
      patients had nonfatal myocardial infarction. In an incremental
      multivariate analysis model, clinical predictors of hard cardiac events
      were history of congestive heart failure, previous myocardial infarction,
      hypercholesterolemia, and ejection fraction at rest. The percentage of
      ischemic segments was incremental to the clinical model in the prediction
      of hard cardiac events (chi(2) = 37 vs. 18, P &lt; 0.05). Clinical predictors
      of all causes of mortality were history of congestive heart failure, age,
      hypercholesterolemia, and ejection fraction at rest. Wall motion score
      index at peak stress was incremental to the clinical model in the
      prediction of mortality (chi(2) = 52 vs. 43, P &lt; 0.05). CONCLUSIONS: DSE
      provides incremental data for the prediction of mortality and hard cardiac
      events in patients with diabetes who are unable to perform an adequate
      exercise stress test.</description>
    </item> <item>
      <title>Preload dependence of new Doppler techniques limits their utility for left ventricular diastolic function assessment in hemodialysis patients (Article)</title>
      <link>http://repub.eur.nl/res/pub/10185/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>Left ventricular (LV) hypertrophy leads to diastolic dysfunction. Standard
      Doppler transmitral and pulmonary vein (PV) flow velocity measurements are
      preload dependent. New techniques such as mitral annulus velocity by
      Doppler tissue imaging (DTI) and LV inflow propagation velocity measured
      from color M-mode have been proposed as relatively preload-independent
      measurements of diastolic function. These parameters were studied before
      and after hemodialysis (HD) with ultrafiltration to test their potential
      advantage for LV diastolic function assessment in HD patients. Ten
      patients (seven with LV hypertrophy) underwent Doppler echocardiography 1
      h before, 1 h after, and 1 d after HD. Early (E) and atrial (A) peak
      transmitral flow velocities, peak PV systolic (s) and diastolic (d) flow
      velocities, peak e and a mitral annulus velocities in DTI, and early
      diastolic LV flow propagation velocity (V(p)) were measured. In all
      patients, the E/A ratio after HD (0.54; 0.37 to 1.02) was lower (P &lt; 0.01)
      than before HD (0.77; 0.60 to 1.34). E decreased (P &lt; 0.01), whereas A did
      not. PV s/d after HD (2.15; 1.08 to 3.90) was higher (P &lt; 0.01) than
      before HD (1.80; 1.25 to 2.68). Tissue e/a after HD (0.40; 0.26 to 0.96)
      was lower (P &lt; 0.01) than before HD (0.56; 0.40 to 1.05). Tissue e
      decreased (P &lt; 0.02), whereas a did not. V(p) after HD (30 cm/s; 16 to 47
      cm/s) was lower (P &lt; 0.01) than before HD (45 cm/s; 32 to 60 cm/s).
      Twenty-four hours after the initial measurements values for E/A (0.59;
      0.37 to 1.23), PV s/d (1.85; 1.07 to 3.38), e/a (0.41; 0.27 to 1.06), and
      V(p) (28 cm/s; 23 to 33 cm/s) were similar as those taken 1 h after HD. It
      is concluded that, even when using the newer Doppler techniques DTI and
      color M-mode, pseudonormalization, which was due to volume overload before
      HD, resulted in underestimation of the degree of diastolic dysfunction.
      Therefore, the advantage of these techniques over conventional parameters
      for the assessment of LV diastolic function in HD patients is limited.
      Assessment of LV diastolic function should not be performed shortly before
      HD, and its time relation to HD is essential.</description>
    </item> <item>
      <title>Assessment of left ventricular function by three-dimensional echocardiography. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13202/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>Accurate determination of LV volume, ejection fraction and segmental wall
      motion abnormalities is important for clinical decision-making and
      follow-up assessment. Currently, echocardiography is the most common used
      method to obtain this information. Three-dimensional echocardiography has
      shown to be an accurate and reproducible method for LV quantitation,
      mainly by avoiding the use of geometric assumptions. In this review, we
      describe various methods to acquire a 3D-dataset for LV volume and wall
      motion analysis, including their advantages and limitations. We provide an
      overview of studies comparing LV volume and function measurement by
      various gated and real-time methods of acquisition compared to magnetic
      resonance imaging. New technical improvements, such as automated
      endocardial border detection and contrast enhancement, will make accurate
      on-line assessment with little operator interaction possible in the near
      future.</description>
    </item> <item>
      <title>Dynamic three-dimensional echocardiography combined with semi-automated border detection offers advantages for assessment of resynchronization therapy. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13261/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>Simultaneous electrical stimulation of both ventricles in patients with
      interventricular conduction disturbance and advanced heart failure
      improves hemodynamics and results in increased exercise tolerance, quality
      of life. We have developed a novel technique for the assessment and
      optimization of resynchronization therapy. Our approach is based on
      transthoracic dynamic three-dimensional (3D) echocardiography and allows
      determination of the most delayed contraction site of the left ventricle
      (LV) together with global LV function data. Our initial results suggest
      that fast reconstruction of the LV is feasible for the selection of the
      optimal pacing site and allows identifying LV segments with dyssynchrony.</description>
    </item> <item>
      <title>A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery (Article)</title>
      <link>http://repub.eur.nl/res/pub/8299/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: To evaluate the discriminatory value and compare the predictive
      performance of six non-invasive tests used for perioperative cardiac risk
      stratification in patients undergoing major vascular surgery. DESIGN:
      Meta-analysis of published reports. METHODS: Eight studies on ambulatory
      electrocardiography, seven on exercise electrocardiography, eight on
      radionuclide ventriculography, 23 on myocardial perfusion scintigraphy,
      eight on dobutamine stress echocardiography, and four on dipyridamole
      stress echocardiography were selected, using a systematic review of
      published reports on preoperative non-invasive tests from the Medline
      database (January 1975 and April 2001). Random effects models were used to
      calculate weighted sensitivity and specificity from the published results.
      Summary receiver operating characteristic (SROC) curve analysis was used
      to evaluate and compare the prognostic accuracy of each test. The relative
      diagnostic odds ratio was used to study the differences in diagnostic
      performance of the tests. RESULTS: In all, 8119 patients participated in
      the studies selected. Dobutamine stress echocardiography had the highest
      weighted sensitivity of 85% (95% confidence interval (CI) 74% to 97%) and
      a reasonable specificity of 70% (95% CI 62% to 79%) for predicting
      perioperative cardiac death and non-fatal myocardial infarction. On SROC
      analysis, there was a trend for dobutamine stress echocardiography to
      perform better than the other tests, but this only reached significance
      against myocardial perfusion scintigraphy (relative diagnostic odds ratio
      5.5, 95% CI 2.0 to 14.9). CONCLUSIONS: On meta-analysis of six
      non-invasive tests, dobutamine stress echocardiography showed a positive
      trend towards better diagnostic performance than the other tests, but this
      was only significant in the comparison with myocardial perfusion
      scintigraphy. However, dobutamine stress echocardiography may be the
      favoured test in situations where there is valvar or left ventricular
      dysfunction.</description>
    </item> <item>
      <title>Quantification of regional left ventricular function in Q wave and non-Q wave dysfunctional regions by tissue Doppler imaging in patients with ischaemic cardiomyopathy (Article)</title>
      <link>http://repub.eur.nl/res/pub/8300/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: To quantify regional left ventricular (LV) function and
      contractile reserve in Q wave and non-Q wave regions in patients with
      previous myocardial infarction. DESIGN: An observational study. SETTING:
      Tertiary care centre. PATIENTS: 81 patients with previous myocardial
      infarction and depressed LV function. INTERVENTIONS: All patients
      underwent surface ECG at rest and pulsed wave tissue Doppler imaging at
      rest and during low dose dobutamine infusion. The left ventricle was
      divided into four major regions (anterior, inferoposterior, septal, and
      lateral). Severely hypokinetic, akinetic, and dyskinetic regions on two
      dimensional echocardiography at rest were considered dysfunctional. MAIN
      OUTCOME MEASURES: Regional myocardial systolic velocity (Vs) at rest and
      the change in Vs during low dose dobutamine infusion (DeltaVs) in
      dysfunctional regions with and without Q waves on surface ECG. RESULTS:
      220 (69%) regions were dysfunctional; 60 of these regions corresponded to
      Q waves and 160 were not related to Q waves. Vs and DeltaVs were lower in
      dysfunctional than in non-dysfunctional regions (mean (SD) Vs 6.2 (1.9)
      cm/s v 7.1 (1.7) cm/s (p &lt; 0.001), and DeltaVs 1.9 (1.9) cm/s v 2.6 (2.5)
      cm/s (p = 0.009), respectively). There were no significant differences in
      Vs and DeltaVs among dysfunctional regions with and without Q waves (Q
      wave regions: Vs 6.2 (1.8) cm/s, DeltaVs 1.6 (2.2) cm/s; non-Q wave
      regions: Vs 6.3 (1.9) cm/s, DeltaVs 2.0 (2.0) cm/s). CONCLUSIONS:
      Quantitative pulsed wave tissue Doppler demonstrated that, among
      dysfunctional regions, Q waves on the ECG do not indicate more severe
      dysfunction, and myocardial contractile reserve is comparable in Q wave
      and non-Q wave dysfunctional myocardium.</description>
    </item> <item>
      <title>Clinical utility and cost effectiveness of a personal ultrasound imager for cardiac evaluation during consultation rounds in patients with suspected cardiac disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/8352/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: To assess the clinical utility and cost effectiveness of a
      personal ultrasound imager (PUI) during consultation rounds for cardiac
      evaluation of patients with suspected cardiac disease. METHODS: 107
      unselected patients from non-cardiac departments (55% men) were enrolled
      in the study. After the physical examination the consultant cardiologist
      performed an echocardiographic study with a PUI. The final report was
      given instantly to the referring physician. All patients subsequently
      underwent a study with a standard echocardiographic device (SED). For each
      patient the consultant cardiologist noted whether the findings of the PUI
      were adequate for final diagnosis. The total cost when full
      echocardiography was used was compared with the cost when the PUI was
      used. The time interval from request to diagnosis was also compared.
      RESULTS: In 84 (78.5%) patients no further examination with an SED was
      regarded as necessary. Twenty three patients (21.5%) required a further
      detailed examination with the SED because of the need for haemodynamic
      information. There was an excellent agreement for the detection of
      abnormalities between the two devices (96%). The total cost was euro;132
      per patient with the SED and euro;75 per patient with the PUI. According
      to this study, the use of the PUI can lead to a 33.4% reduction of total
      cost. The mean time from request to diagnosis at the authors' institution
      was four days for the SED and instantly for the PUI, for additional
      potential cost savings. CONCLUSIONS: Immediate echocardiographic
      assessment during consultation rounds can lead to significant cost savings
      and can shorten the time to diagnosis.</description>
    </item> <item>
      <title>A personal ultrasound imager (ultrasound stethoscope). A revolution in the physical cardiac diagnosis! (Article)</title>
      <link>http://repub.eur.nl/res/pub/13056/</link>
      <pubDate>2002-04-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Long-term prognostic value of dobutamine stress 99mTc-sestamibi SPECT: single-center experience with 8-year follow-up (Article)</title>
      <link>http://repub.eur.nl/res/pub/10026/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>PURPOSE: To determine the long-term prognostic value of dobutamine stress
      technetium 99m (99mTc)-labeled sestamibi single photon emission computed
      tomography (SPECT) in patients with limited exercise capacity. MATERIALS
      AND METHODS: Clinical data and SPECT results were analyzed in 531
      consecutive patients. Follow-up was successful in 528 (99.4%) patients; 55
      underwent early revascularization and were excluded. Normal or abnormal
      findings were considered in the absence or presence of fixed and/or
      reversible perfusion defects. A summed stress score was calculated to
      estimate the extent and severity of perfusion defects. Univariate and
      multivariate Cox proportional hazards regression models were used to
      identify independent predictors of late cardiac events. The incremental
      value of myocardial perfusion scintigraphy over clinical variables in
      predicting events was determined according to two models. The probability
      of survival was calculated by using the Kaplan-Meier method. RESULTS:
      Findings were abnormal in 312 patients. During 8.0 years +/- 1.5 of
      follow-up (range, 4.5-10.6 years), cardiac death occurred in 67 patients
      (total deaths, 165); nonfatal myocardial infarction, in 34; and late
      revascularization, in 49. The annual rates for cardiac death, cardiac
      death or infarction, and all events were 0.9%, 1.2%, and 1.5%,
      respectively, after normal findings and 2.7%, 3.4%, and 4.4%,
      respectively, after abnormal findings (P &lt;.05). In a multivariable Cox
      proportional hazards model, not only an abnormal finding but also the
      summed stress score provided incremental prognostic information in
      addition to clinical data. The hazard ratio for cardiac death was 1.09
      (95% CI: 1.01, 1.18) per 1-unit increment of the summed stress score.
      CONCLUSION: The incremental prognostic value of dobutamine stress
      99mTc-sestamibi SPECT over clinical data was maintained over an 8-year
      follow-up in patients with limited exercise capacity.</description>
    </item> <item>
      <title>Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction (Article)</title>
      <link>http://repub.eur.nl/res/pub/8329/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: To assess the prevalence of myocardial viability by
      technetium-99m (Tc-99m)-tetrofosmin/fluorine-18-fluorodeoxyglucose (FDG)
      single photon emission computed tomography (SPECT) in patients with
      ischaemic cardiomyopathy. DESIGN: A retrospective observational study.
      SETTING: Thoraxcenter Rotterdam (a tertiary referral centre). PATIENTS:
      104 patients with chronic coronary artery disease and severely depressed
      left ventricular function presenting with heart failure symptoms. MAIN
      OUTCOME MEASURES: Prevalence of myocardial viability as evaluated by
      Tc-99m-tetrofosmin/FDG SPECT imaging. Two strategies for assessing
      viability in dysfunctional myocardium were used: perfusion imaging alone,
      and the combination of perfusion and metabolic imaging. RESULTS: On
      perfusion imaging alone, 56 patients (54%) had a significant amount of
      viable myocardium, whereas 48 patients (46%) did not. Among the 48
      patients with no significant viability by perfusion imaging alone, seven
      additional patients (15%) had significantly viable myocardium on combined
      perfusion and metabolic imaging. Thus with a combination of perfusion and
      metabolic imaging, 63 patients (61%) had viable myocardium and 41 (39%)
      did not. CONCLUSIONS: On the basis of the presence of viable dysfunctional
      myocardium, 61% of patients with chronic coronary artery disease and
      depressed left ventricular ejection fraction presenting with heart failure
      symptoms may be considered for coronary revascularisation. The combination
      of perfusion and metabolic imaging identified more patients with
      significant viability than myocardial perfusion imaging alone.</description>
    </item> <item>
      <title>Deterioration of left ventricular function following atrio-ventricular node ablation and right ventricular apical pacing in patients with permanent atrial fibrillation (Article)</title>
      <link>http://repub.eur.nl/res/pub/9852/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>AIMS: Transcatheter radiofrequency ablation of the atrio-ventricular (AV)
      node followed by ventricular pacing has been shown to improve symptoms and
      quality of life of patients with atrial fibrillation (AF). It is assumed
      that function improves, but this has been less well demonstrated. The aim
      of this study was to assess the long-term effect of AV node ablation and
      ventricular pacing on left ventricular ejection fraction (LVEF) in
      patients with permanent AF. METHODS AND RESULTS: All 12 patients studied
      had permanent AF for at least 12 months (mean age 70 years, range 41 to
      78). LVEF was determined 6 days and 3 months after AV node ablation by
      radionuclide ventriculography, at a paced rate of 80 beats . min (-1).
      Cardiac dimensions were measured by means of transthoracic
      echocardiography. No major changes in pharmacological therapy were made
      during 3 months follow-up period. LVEF showed a significant deterioration
      after 3 months follow-up period for the group (47.5 +/- 14.4%; 6 days
      after ablation vs 43.2 +/- 13.7%; 3 months after ablation, P &lt; 0.05).
      There were no significant differences in left ventricular cavity
      dimensions directly after AV node ablation and 3 months later (LVEDD 51.2
      +/- 10.7 mm vs 52.6 +/- 8.6 mm, P = NS: LVESD: 36.1 +/- 14.2 mm vs 36.6
      +/- 9.7 mm, P = NS). Left atrial size did not show reduction 3 months
      after AV node ablation (50.8 +/- 13.6 mm vs 51.0 +/- 14.1 mm, P = NS).
      CONCLUSION: The restoration of a regular ventricular rhythm following AV
      node ablation for patients in permanent AF does not result in improvement
      in left ventricular function.</description>
    </item> <item>
      <title>Prognostic value of dobutamine-atropine stress myocardial perfusion imaging in patients with diabetes (Article)</title>
      <link>http://repub.eur.nl/res/pub/9963/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: Exercise tolerance in patients with diabetes is frequently
      impaired due to noncardiac disease such as claudication and
      polyneuropathy. This study assesses the prognostic value of dobutamine
      stress myocardial perfusion imaging in patients with diabetes. RESEARCH
      DESIGN AND METHODS: A total of 207 consecutive diabetic patients who were
      unable to undergo exercise stress testing underwent dobutamine-atropine
      stress myocardial perfusion imaging. Follow-up was successful in 206 of
      207 (99.5%) patients. A total of 12 patients underwent early (&lt;60 days)
      revascularization and were excluded from the analysis. End points during
      follow-up were hard cardiac events, defined as cardiac death and nonfatal
      myocardial infarction. RESULTS: Abnormal myocardial perfusion was detected
      in 125 (64%) patients. During 4.1 +/- 2.4 years of follow-up, 73 (38%)
      deaths occurred, 36 (49%) of which were due to cardiac causes. Nonfatal
      myocardial infarction occurred in 7 (4%) patients, and 45 (23%) patients
      underwent late coronary revascularization. Cardiac death occurred in 2 of
      69 (3%) patients with normal myocardial perfusion and in 34 of 125 (27%)
      patients with perfusion abnormalities (P &lt; 0.0001). A multivariable Cox
      proportional hazard model demonstrated that, in addition to clinical and
      stress test data, an abnormal scan had an incremental prognostic value for
      prediction of cardiac death (hazard ratio 7.2, 95% CI 1.7-30). The summed
      stress score was an important predictor of cardiac death; the hazard ratio
      was 1.2 (95% CI 1.07-1.34) per one-unit increment. CONCLUSIONS:
      Dobutamine-atropine stress myocardial perfusion imaging provides
      additional prognostic information incremental to clinical data in patients
      with diabetes who are unable to undergo exercise stress testing.</description>
    </item> <item>
      <title>Left ventricular hypertrophy screening using a hand-held ultrasound device (Article)</title>
      <link>http://repub.eur.nl/res/pub/9975/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>AIMS: To test the diagnostic potential of a hand-held ultrasound device
      for screening for left ventricular hypertrophy in a hypertensive
      population using a standard echocardiographic system as a reference.
      METHODS: One hundred consecutive hypertensive patients were enrolled. An
      experienced investigator performed measurements of the thickness of the
      anterior septum and posterior wall using the parasternal 2D-long axis view
      and the end-diastolic dimension of the left ventricle with both imaging
      devices. Left ventricular hypertrophy was defined as an increase in left
      ventricular mass &gt; or = 134 g x m(-2) for men and &gt; or = 110 g x m(-2) for
      women, when indexed for body surface area and &gt; or = 143 g x m(-1) for men
      and &gt; or = 102 g x m(-1) for women, when indexed for height. RESULTS:
      Sixty-five men and 35 women were studied (age 60 +/- 11 years); mean
      duration of hypertension: 13 +/- 11 years; mean blood pressures: systolic
      150 +/- 20 mmHg and diastolic 89 +/- 11 mmHg. The anterior septum and
      posterior wall were visualized in all patients with both imaging devices.
      The standard echocardiographic system identified left ventricular
      hypertrophy by body surface area in 18 (18%) patients and by height in 26
      (26%) patients. The agreement between the standard echocardiographic
      system and the hand-held device for the assessment of left ventricular
      hypertrophy was 93%, kappa: 0.77 (left ventricular mass/body surface area)
      and 90%, kappa: 0.76 (left ventricular mass/height). CONCLUSIONS: We
      conclude that hand-held devices can be effectively applied for screening
      for left ventricular hypertrophy in hypertensive patients.</description>
    </item> <item>
      <title>Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. (Article)</title>
      <link>http://repub.eur.nl/res/pub/12934/</link>
      <pubDate>2001-08-22T00:00:00Z</pubDate>
      <description>AIM: To assess the long-term cardioprotective effect of bisoprolol in a
          randomized high-risk population after successful major vascular surgery.
          High-risk patients were defined by the presence of one or more cardiac
          risk factor(s) and a dobutamine echocardiography test positive for
          ischaemia. METHODS: 1351 patients were screened prior to surgery, 846
          patients had one or more risk factor(s), and 173 of these patients also
          had ischaemia during dobutamine echocardiography. One hundred and twelve
          patients could be randomized for additional bisoprolol therapy or standard
          care. Eleven patients died in the peri-operative period (up to 1 month
          after surgery). Randomized patients continued bisoprolol or standard care
          after surgery. During follow-up of 101 survivors (median 22 months, range
          11-30) cardiac death or myocardial infarction was noted. No patient was
          lost during follow-up.Results The incidence of cardiac events during
          follow-up in the bisoprolol group was 12% vs 32% in the standard care
          group (P=0.025). Cardiac death occurred in 15 patients, nine patients in
          the standard care and in six in the bisoprolol group; myocardial
          infarction occurred in six patients, five in the standard care and one in
          the bisoprolol group. The odds ratio for cardiac death or myocardial
          infarction after surgery in high-risk patients with additional bisoprolol
          therapy was 0.30 (0.11-0.83). CONCLUSIONS: Bisoprolol significantly
          reduced long-term cardiac death and myocardial infarction in high-risk
          patients after successful major cardiac vascular surgery.</description>
    </item> <item>
      <title>Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators. (Article)</title>
      <link>http://repub.eur.nl/res/pub/12935/</link>
      <pubDate>2001-07-20T00:00:00Z</pubDate>
      <description>AIM: Inappropriate therapy, due to poor discrimination of supraventricular
      tachycardia (SVT) from ventricular tachycardia (VT) remains a major
      problem in patients with an implantable cardioverter defibrillator (ICD).
      Theoretically, the addition of atrial sensing in discrimination algorithms
      should improve this differentiation. The aim of the study is to evaluate
      the performance of a new tachycardia discrimination algorithm, SMART
      Detection. METHODS AND RESULTS: Twenty-six patients received a
      non-thoracotomy ICD system (Phylax AV, Biotronik, Germany). All documented
      spontaneous arrhythmia episodes were analyzed. During a mean follow-up of
      8 months, a total number of 139 events with stored electrograms were
      recorded in 12 patients. The final diagnosis was ventricular fibrillation
      (VF) or polymorphic VT (n=20), monomorphic VT (n=69), SVT (n=26), other
      ventricular arrhythmia (n=3) and T wave oversensing (n=21). In 6 episodes
      a dual tachycardia was present. Considering SVT episodes, inappropriate
      therapy occurred in 2 cases of atrial flutter due to stable ventricular
      rate (&lt;30 ms), 1 case of atrial tachycardia and 2 cases of sinus
      tachycardia due to a sudden onset (&gt; 10%). CONCLUSION: With the SMART
      Detection algorithm, discrimination of VT from SVT achieved a sensitivity
      of 100%, with an accuracy of 95.6% for all ventricular arrhythmias. In the
      case of SVT, the algorithm appropriately detected and inhibited therapy in
      88% of atrial fibrillation.</description>
    </item> <item>
      <title>Improved identification of viable myocardium using second harmonic imaging during dobutamine stress echocardiography (Article)</title>
      <link>http://repub.eur.nl/res/pub/8312/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: To determine whether, compared with fundamental imaging, second
      harmonic imaging can improve the accuracy of dobutamine stress
      echocardiography for identifying viable myocardium, using nuclear imaging
      as a reference. PATIENTS: 30 patients with chronic left ventricular
      dysfunction (mean (SD) age, 60 (8) years; 22 men). METHODS: Dobutamine
      stress echocardiography was carried out in all patients using both
      fundamental and second harmonic imaging. All patients underwent dual
      isotope simultaneous acquisition single photon emission computed
      tomography (DISA-SPECT) with
      (99m)technetium-tetrofosmin/(18)F-fluorodeoxyglucose on a separate day.
      Myocardial viability was considered present by dobutamine stress
      echocardiography when segments with severe dysfunction showed a biphasic
      sustained improvement or an ischaemic response. Viability criteria on
      DISA-SPECT were normal or mildly reduced perfusion and metabolism, or
      perfusion/metabolism mismatch. RESULTS: Using fundamental imaging, 330
      segments showed severe dysfunction at baseline; 144 (44%) were considered
      viable. The agreement between dobutamine stress echocardiography by
      fundamental imaging and DISA-SPECT was 78%, kappa = 0.56. Using second
      harmonic imaging, 288 segments showed severe dysfunction; 138 (48%) were
      viable. The agreement between dobutamine stress echocardiography and
      DISA-SPECT was significantly better when second harmonic imaging was used
      (89%, kappa = 0.77, p = 0.001 v fundamental imaging). CONCLUSIONS: Second
      harmonic imaging applied during dobutamine stress echocardiography
      increases the agreement with DISA-SPECT for detecting myocardial
      viability.</description>
    </item> <item>
      <title>Transseptal left heart catheterisation guided by intracardiac echocardiography (Article)</title>
      <link>http://repub.eur.nl/res/pub/8348/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: To develop a novel approach of transseptal puncture guided by
      intracardiac echocardiography and to assess its efficacy. METHODS:
      Transcatheter intracardiac echocardiography with a 9 MHz rotating
      transducer was performed to guide transseptal puncture in 12 patients
      (mean age 43.1 years, range 31-68) who underwent radiofrequency catheter
      ablation of left sided accessory pathways. Initially, the echocardiography
      and transseptal catheters were placed adjacent to each other in the
      superior vena cava and were withdrawn to the level of the fossa ovalis.
      RESULTS: The successful puncture site was associated with visualisation of
      the fossa ovalis (12 patients, 100%) and the aorta (12 patients, 100%),
      tenting of the fossa (six patients, 50%), penetration of the needle
      visualised by the ultrasound catheter (12 patients, 100 %), and
      echocardiographic contrast material applied in the left atrium (12
      patients, 100%). The characteristic jump of the needle onto the fossa
      ovalis was observed simultaneously with fluoroscopy and intracardiac
      ultrasound (12 patients, 100%). All procedures were successful. There were
      no complications associated with the transseptal procedure. CONCLUSIONS:
      Intracardiac echocardiography is feasible to guide transseptal puncture.
      The optimal puncture site can be assessed by simultaneous detection of the
      characteristic downward jump of the transseptal needle onto the fossa
      ovalis by intracardiac ultrasound and fluoroscopy.</description>
    </item> <item>
      <title>Human tissue valves in aortic position: determinants of reoperation and valve regurgitation (Article)</title>
      <link>http://repub.eur.nl/res/pub/9616/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Human tissue valves for aortic valve replacement have a
          limited durability that is influenced by interrelated determinants.
          Hierarchical linear modeling was used to analyze the relation between
          these determinants of durability and valve regurgitation measured by
          serial echocardiography. METHODS AND RESULTS: In adult patients, 218
          cryopreserved aortic allografts were implanted with the subcoronary (85)
          or the root replacement technique (133), and 81 patients had root
          replacement with a pulmonary autograft. Mean follow-up was 4.2 years (SD
          2.7; range, 0 to 10.5). Patient age, operator experience with subcoronary
          implantation, and allograft diameter were independent predictors for
          reoperation. With repeated color Doppler echocardiography, the severity of
          aortic regurgitation was assessed by the jet length method and the jet
          diameter ratio. Multilevel hierarchical linear modeling was used to
          estimate initial aortic regurgitation (intercept), its change over time
          (slope), and the effect of 11 potential determinants of durability on
          aortic regurgitation. With the jet length method, the intercept was 0.94
          grade and the slope was 0.11 grade per year. With the jet diameter ratio,
          the intercept was 0.34 and the annual increase was 0.01. Subcoronary
          implanted valves had more initial aortic regurgitation, but progression of
          aortic valve regurgitation did not differ from root replacement. At
          midterm follow-up, recipient age &lt;40 years was the only independent
          predictor of aortic regurgitation. CONCLUSIONS: Subcoronary implantation
          has a learning curve, resulting in more initial aortic regurgitation and
          early reoperation compared with root replacement. In both techniques,
          progression of aortic regurgitation over time is small but accelerated in
          young adults.</description>
    </item> <item>
      <title>Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy (Article)</title>
      <link>http://repub.eur.nl/res/pub/9625/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>CONTEXT: Patients who undergo major vascular surgery are at increased risk
          of perioperative cardiac complications. High-risk patients can be
          identified by clinical factors and noninvasive cardiac testing, such as
          dobutamine stress echocardiography (DSE); however, such noninvasive
          imaging techniques carry significant disadvantages. A recent study found
          that perioperative beta-blocker therapy reduces complication rates in
          high-risk individuals. OBJECTIVE: To examine the relationship of clinical
          characteristics, DSE results, beta-blocker therapy, and cardiac events in
          patients undergoing major vascular surgery. DESIGN AND SETTING: Cohort
          study conducted in 1996-1999 in the following 8 centers: Erasmus Medical
          Centre and Sint Clara Ziekenhuis, Rotterdam, Twee Steden Ziekenhuis,
          Tilburg, Academisch Ziekenhuis Utrecht, Utrecht, and Medisch Centrum
          Alkmaar, Alkmaar, the Netherlands; Ziekenhuis Middelheim, Antwerp,
          Belgium; and San Gerardo Hospital, Monza, Istituto di Ricovero e Cura a
          Carattere Scientifico, San Giovanni Rotondo, Italy. PATIENTS: A total of
          1351 consecutive patients scheduled for major vascular surgery; DSE was
          performed in 1097 patients (81%), and 360 (27%) received beta-blocker
          therapy. MAIN OUTCOME MEASURE: Cardiac death or nonfatal myocardial
          infarction within 30 days after surgery, compared by clinical
          characteristics, DSE results, and beta-blocker use. RESULTS: Forty-five
          patients (3.3%) had perioperative cardiac death or nonfatal myocardial
          infarction. In multivariable analysis, important clinical determinants of
          adverse outcome were age 70 years or older; current or prior angina
          pectoris; and prior myocardial infarction, heart failure, or
          cerebrovascular accident. Eighty-three percent of patients had less than 3
          clinical risk factors. Among this subgroup, patients receiving
          beta-blockers had a lower risk of cardiac complications (0.8% [2/263])
          than those not receiving beta-blockers (2.3% [20/855]), and DSE had
          minimal additional prognostic value. In patients with 3 or more risk
          factors (17%), DSE provided additional prognostic information, for
          patients without stress-induced ischemia had much lower risk of events
          than those with stress-induced ischemia (among those receiving
          beta-blockers, 2.0% [1/50] vs 10.6% [5/47]). Moreover, patients with
          limited stress-induced ischemia (1-4 segments) experienced fewer cardiac
          events (2.8% [1/36]) than those with more extensive ischemia (&gt;/=5
          segments, 36% [4/11]). CONCLUSION: The additional predictive value of DSE
          is limited in clinically low-risk patients receiving beta-blockers. In
          clinical practice, DSE may be avoided in a large number of patients who
          can proceed safely for surgery without delay. In clinically intermediate-
          and high-risk patients receiving beta-blockers, DSE may help identify
          those in whom surgery can still be performed and those in whom cardiac
          revascularization should be considered.</description>
    </item> <item>
      <title>Aneurysm of the abdominal aorta (Article)</title>
      <link>http://repub.eur.nl/res/pub/9686/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Real-time quantification and display of skin radiation during coronary angiography and intervention (Article)</title>
      <link>http://repub.eur.nl/res/pub/9771/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Radiographically guided investigations may be associated with excessive radiation exposure, which may cause skin injuries. The purpose of this study was to develop and test a system that measures in real time the dose applied to each 1-cm(2) area of skin, taking into account the movement of the x-ray source and changes in the beam characteristics. The goal of such a system is to help prevent high doses that might cause skin injury. METHODS AND RESULTS: The entrance point, beam size, and dose at the skin of the patient were calculated by use of the geometrical settings of gantry, investigation table, and x-ray beam and an ionization chamber. The data are displayed graphically. Three hundred twenty-two sequential cardiac investigations in adult patients were analyzed. The mean peak entrance dose per investigation was 0.475 Gy to a mean skin area of 8.2 cm(2). The cumulative KERMA-area product per investigation was 52.2 Gy/cm(2) (25.4 to 99.2 Gy/cm(2)), and the mean entrance beam size at the skin was 49.2 cm(2). Twenty-eight percent of the patients (90/322) received a maximum dose of &lt;1 Gy to a small skin area ( approximately 6 cm(2)), and 13.5% of the patients (42/322) received a maximum dose of &gt;2 Gy. CONCLUSIONS: Monitoring of the dose distribution at the skin will alert the operator to the development of high-dose areas; by use of other gantry settings with nonoverlapping entrance fields, different generator settings, and extra collimation, skin lesion can be avoided.</description>
    </item> <item>
      <title>Comparison of mechanical properties of the left ventricle in patients with severe coronary artery disease by nonfluoroscopic mapping versus two-dimensional echocardiograms. (Article)</title>
      <link>http://repub.eur.nl/res/pub/4858/</link>
      <pubDate>2000-11-01T00:00:00Z</pubDate>
      <description>In 40 patients, we compared linear local shortening assessed with nonfluoroscopic electromechanical mapping as a function of regional wall motion with echocardiographic data in a subset of patients with severe coronary artery disease and subsequently decreased left ventricular function. Our study showed that nonfluoroscopic electromechanical mapping can accurately assess regional wall motion. In addition, this study showed a significant decrease in unipolar voltages among segments with declining regional function.</description>
    </item> <item>
      <title>Usefulness and limitations of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in patients with left bundle branch block. A multicentre study. (Article)</title>
      <link>http://repub.eur.nl/res/pub/12886/</link>
      <pubDate>2000-10-30T00:00:00Z</pubDate>
      <description>BACKGROUND: Patients with left bundle branch block exhibit abnormal septal
      motion which may limit the interpretation of stress echocardiograms. This
      study sought to assess the diagnostic value of dobutamine-atropine stress
      echocardiography in left bundle branch block patients. METHODS AND
      RESULTS: Sixty-four left bundle branch block patients (mean age 59 years,
      24 men) with suspected coronary artery disease underwent
      dobutamine-atropine stress echocardiography and coronary arteriography.
      Myocardial ischaemia was defined as new or worsening wall thickening
      abnormalities. Coronary artery disease was quantitatively defined as a
      diameter stenosis &gt;/=50% in a major epicardial artery. Rest septal motion
      was normal (apart from the early systolic septal notch) in 34 patients
      (53%) and abnormal in 30 patients (47%). Rest septal thickening was normal
      in 32 patients (50%) and abnormal in 32 patients (50%). All seven patients
      with a QRS duration &gt;/=160 ms and an abnormal QRS axis had abnormal rest
      septal motion and thickening. Inter-observer agreement for ischaemia was
      88%. In all but one patient disagreement was in the septum. For the
      anterior and posterior circulation, respectively, sensitivity was 60%
      (9/15) and 67% (8/12), specificity was 94% (46/49) and 98% (51/52), and
      accuracy was 86% (55/64) and 92% (59/64). Sensitivity for the anterior
      circulation tended to be better in patients with normal rest septal
      thickening (83% vs 44%). CONCLUSIONS: Dobutamine-atropine stress
      echocardiography has excellent diagnostic specificity in left bundle
      branch block patients with suspected coronary artery disease. In patients
      with abnormal rest septal thickening, however, dobutamine-atropine stress
      echocardiography may lack good sensitivity for detection of coronary
      artery disease in the anterior circulation. Left bundle branch block
      patients who potentially most benefit from dobutamine-atropine stress
      echocardiography may initially be selected by their resting
      electrocardiogram.</description>
    </item> <item>
      <title>Doppler tissue velocity sampling improves diagnostic accuracy during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. (Article)</title>
      <link>http://repub.eur.nl/res/pub/12877/</link>
      <pubDate>2000-07-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Both nuclear imaging with F18-fluorodeoxyglucose and
          dobutamine stress echocardiography have been used to identify viable
          myocardium, although dobutamine-stress echocardiography has been
          demonstrated to be the less sensitive of the two. AIM: To compare the
          accuracy of pulsed-wave Doppler tissue sampling with dobutamine-stress
          echocardiography for the detection of viable myocardium, using
          F18-fluorodeoxyglucose imaging as a reference. Methods Forty patients with
          chronic coronary artery disease and left ventricular dysfunction (mean
          ejection fraction 33+/-11%), underwent F18-fluorodeoxyglucose imaging,
          dobutamine-stress echocardiography and pulsed-wave Doppler tissue
          sampling. Evaluation was performed using a six-segment model. RESULTS:
          Visual assessment by resting echo was feasible in 230 out of 240 segments
          (96%); 177 (77%) segments showed severe dyssynergy at rest.
          F18-fluorodeoxyglucose imaging showed viability in 95 (54%) segments while
          82 (46%) were non-viable. Ejection phase velocity at rest was not
          significantly different; ejection velocities during low-dose and peak-dose
          dobutamine, however, were significantly higher in viable myocardium
          (8.6+/-2.9 vs 6.0+/-1.8 and 9.3+/-3.1 vs 6.2+/-2.1 cm x s(-1)). Using
          receiver operating characteristic curves the optimal cut-off value for
          viability assessment was an increase in the ejection phase velocity
          low-dose of 1+/-0.5 cm x s(-1), while 0+/-0.5 cm x s(-1)predicted
          non-viability. The sensitivity and specificity (95%CI) of pulsed-wave
          Doppler tissue sampling and dobutamine-stress echocardiography for the
          prediction of viability was respectively 87% (82-92) vs 75% (67-81)
          (P&lt;0.05) and 52% (44-59) vs 51% (45-59) (P=ns). CONCLUSIONS: The
          sensitivity of pulsed-wave Doppler tissue sampling is superior to
          dobutamine-stress echocardiography for the assessment of myocardial
          viability.</description>
    </item> <item>
      <title>Safety and prognostic value of early dobutamine-atropine stress echocardiography in patients with spontaneous chest pain and a non-diagnostic electrocardiogram. (Article)</title>
      <link>http://repub.eur.nl/res/pub/12831/</link>
      <pubDate>2000-03-04T00:00:00Z</pubDate>
      <description>AIMS: To risk stratify and shorten hospital stay in patients with
      spontaneous (resting) chest pain and a non-diagnostic electrocardiogram
      (ECG). METHODS AND RESULTS: The study comprised 102 patients (mean age
      58+/-12 years, 67 men) with spontaneous chest pain and a non-diagnostic
      ECG. Forty-three patients had suspected coronary artery disease and 59 had
      known (but of unknown actual significance) coronary artery disease. All
      patients underwent serial creatine kinase enzyme measurements, continuous
      ECG monitoring for at least 12 h and early dobutamine-atropine stress
      echocardiography in patients with negative creatine kinase enzymes and
      normal findings at ECG monitoring. Dobutamine-atropine stress
      echocardiography was considered positive in patients with new or worsening
      wall thickening abnormalities. Patients with negative dobutamine-atropine
      stress echocardiography were discharged after the test. In-hospital and 6
      month follow-up events noted were cardiac death, non-fatal myocardial
      infarction, unstable angina, and coronary artery bypass surgery or
      angioplasty. Thirteen patients had evidence of evolving myocardial
      infarction by elevated creatine kinase enzymes, or unstable angina by ECG
      monitoring. In the remaining 89 patients, dobutamine-atropine stress
      echocardiography was performed after a median observation period of 31 h
      (range 12-68 h). During dobutamine-atropine stress echocardiography no
      serious complications (death, non-fatal myocardial infarction, sustained
      ventricular tachycardia or ventricular fibrillation) occurred.
      Dobutamine-atropine stress echocardiography results were of poor quality
      in three, non-diagnostic in six, negative in 44 and positive in 36
      patients. In the 80 patients with diagnostic dobutamine-atropine stress
      echocardiography, variables associated with in-hospital events (n=7) were
      history of exertional angina (P&lt;0. 005), chest pain score (P&lt;0.005),
      stress-induced angina (P&lt;0.001) and positive dobutamine-atropine stress
      echocardiography (P&lt;0.005). Variables associated with follow-up events
      (n=11) were history of exertional angina (P&lt;0.05), chest pain score
      (P&lt;0.001), stress-induced angina (P&lt;0.01) and positive dobutamine-atropine
      stress echocardiography (P&lt;0.01). At multivariate analysis the only
      significant predictor of events was positive dobutamine-atropine stress
      echocardiography (P&lt;0.01). CONCLUSION: Early dobutamine-atropine stress
      echocardiography may safely distinguish between low- and high-risk subsets
      for subsequent cardiac events in patients with spontaneous chest pain and
      a non-diagnostic ECG.</description>
    </item> <item>
      <title>The grade of worsening of regional function during dobutamine stress echocardiography predicts the extent of myocardial perfusion abnormalities (Article)</title>
      <link>http://repub.eur.nl/res/pub/9224/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>AIM: To evaluate the angiographic, myocardial perfusion, and wall motion
          abnormalities in patients with severe compared with mild worsening of
          regional function during dobutamine stress echocardiography (DSE) for
          evaluation of myocardial ischaemia. METHODS: 147 patients with significant
          coronary artery disease and new or worsening wall motion abnormalities
          during DSE were enrolled. Left ventricular function was evaluated using a
          16 segment/4 grade score model where 1 = normal and 4 = dyskinesis.
          Simultaneous sestamibi SPECT myocardial perfusion imaging was performed in
          all patients. RESULTS: Severe worsening of regional function (an increase
          in wall motion score of two grades or more in &gt;/= 1 segment) was detected
          in 37 patients, while 110 patients had mild worsening (an increase in wall
          motion score of no more than one grade in &gt;/= 1 segment). Patients with
          severe worsening of regional function had more stenotic coronary arteries
          (2.31 (0.8) v 1.97 (0. 8) (mean (SD)) (p &lt;0.05), a higher prevalence of
          left anterior descending coronary artery disease (95% v 73%) (p &lt; 0.05), a
          higher resting wall motion score index (1.71 (0.42) v 1.51 (0.40) (p = 0.
          01), and more stress perfusion defects (3.8 (1.5) v 2.8 (1.5) (p &lt; 0.001)
          compared with patients with mild worsening. Multivariate analysis
          identified the number of stress perfusion defects (p &lt; 0. 005, chi(2) =
          8.8) and the number of ischaemic segments on echocardiography (p &lt; 0.05,
          chi(2) = 4.3) as independent variables associated with severe worsening of
          regional function. CONCLUSIONS: The grade of worsening of regional
          function during DSE predicts the underlying extent of myocardial perfusion
          abnormalities. The occurrence of severe worsening of regional function is
          associated with variables known to predict worse prognosis in patients
          with coronary artery disease.</description>
    </item> <item>
      <title>Images in Cardiovascular Medicine. Aberrant right subclavian artery mimics aortic dissection (Article)</title>
      <link>http://repub.eur.nl/res/pub/9241/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Safety, hemodynamic profile, and feasibility of dobutamine stress technetium myocardial perfusion single-photon emission CT imaging for evaluation of coronary artery disease in the elderly (Article)</title>
      <link>http://repub.eur.nl/res/pub/9286/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVES: Cardiovascular disease is the leading cause of morbidity and
          mortality in the elderly. The evaluation of coronary artery disease by
          exercise stress testing is frequently limited by the patient's inability
          to exercise. Although pharmacologic stress testing with dobutamine is an
          alternative, the safety of dobutamine myocardial perfusion scintigraphy in
          the elderly has not been previously studied. PATIENTS AND METHODS: We
          studied the safety and feasibility of dobutamine (up to 40
          microg/kg/min)-atropine (up to 1 mg) stress myocardial perfusion
          scintigraphy using technetium single-photon emission CT imaging in 227
          patients &gt; or = 70 years old (mean +/- SD age, 75 +/- 4 years). A control
          group of 227 patients &lt; 70 years old (mean age, 55 +/- 11 years; matched
          for gender, prevalence of previous infarction, beta-blocker therapy, and
          severity of resting perfusion abnormalities) was studied to assess
          age-related differences in the safety and the hemodynamic response. A
          feasible test was defined as the achievement of the target heart rate
          and/or an ischemic end point (angina, ST-segment depression, or reversible
          perfusion abnormalities). RESULTS: No myocardial infarction or death
          occurred during the test. The target heart rate was achieved more
          frequently in the elderly patients (87% vs 79%; p &lt; 0.05). The elderly
          patients had a higher prevalence of supraventricular tachycardia (7% vs
          1%; p &lt; 0.005) and premature ventricular contraction (74% vs 32%; p &lt;
          0.005) during the test, as compared to the younger patients. There was a
          trend to a higher prevalence of ventricular tachycardia (5% vs 2%) and
          atrial fibrillation (3% vs 0.4%) in the elderly patients. Arrhythmias were
          terminated spontaneously by termination of dobutamine infusion or by
          administration of metoprolol. Independent predictors of supraventricular
          tachyarrhythmias and ventricular tachycardia were older age (p &lt; 0.001;
          chi(2), 9.8) and myocardial perfusion defect score at rest (p &lt; 0.01;
          chi(2), 6.8) respectively, by using a multivariate analysis of clinical
          and stress test variables. Elderly patients had a higher prevalence of
          systolic BP drop &gt; 20 mm Hg during the test (37% vs 12%; p &lt; 0.05). The
          test was terminated due to hypotension in 2% of the elderly patients and
          in 1% of the control group. Age was the most powerful predictor of
          hypotension (p &lt; 0.005; chi(2), 10.3). The test was considered feasible in
          216 elderly patients (95%) and in 209 patients of the control group (92%).
          CONCLUSION: Dobutamine-atropine stress myocardial perfusion scintigraphy
          is a highly feasible method for the evaluation of coronary artery disease
          in the elderly. Elderly patients have a higher risk for developing
          hypotension and supraventricular tachyarrhythmias during a dobutamine
          stress test. However, dobutamine-induced hypotension is often asymptomatic
          and rarely necessitates the termination of the test.</description>
    </item> <item>
      <title>Long-Term Prognostic Value of Dobutamine-Atropine Stress Echocardiography in 1737 Patients With Known or Suspected Coronary Artery Disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/5588/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>Background—The purpose of this study was to assess the long-term value of dobutamine-atropine stress echocardiography (DSE) for prediction of late cardiac events in patients with proven or suspected coronary artery disease.

Methods and Results—Clinical data and DSE results were analyzed in 1734 consecutive patients undergoing DSE between 1989 and 1997. Seventy-four patients who underwent revascularization within 3 months of DSE and 1 patient lost to follow-up were excluded; the remaining 1659 (median age, 62 years; range, 14 to 99 years) were followed up for 36 months (range, 6 to 96 months). Wall motion abnormalities at rest and the presence and extent of stress-induced wall motion abnormalities (ischemia) were scored for each patient. Cardiac events were related to clinical and ECG data and DSE results. Four hundred twenty-eight cardiac events occurred in 366, documented cardiac death in 108 (total death, 247), nonfatal infarction in 128, and late revascularization in 192 patients. In a multivariable Cox proportional-hazards model, the ratio of documented cardiac death or (re)infarction was increased in the presence of stress-induced ischemia (hazard ratio, 3.3; 95% CI, 2.4 to 4.4) and extensive rest wall motion abnormalities (hazard ratio, 1.9; 95% CI, 1.3 to 2.6). The number of ischemic segments was predictive for late cardiac events. A normal DSE carried a relatively good prognosis, with an annual event rate of cardiac death or infarction of 1.3% over a 5-year period.

Conclusions—In a large group of patients, DSE has an added value for predicting late cardiac events during long-term follow-up, improving the separation between high- risk and very-low-risk patients.</description>
    </item> <item>
      <title>Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: A single-center experience (Article)</title>
      <link>http://repub.eur.nl/res/pub/9019/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND--The purpose of this study was to assess the long-term value of
      dobutamine-atropine stress echocardiography (DSE) for prediction of late
      cardiac events in patients with proven or suspected coronary artery
      disease. METHODS AND RESULTS--Clinical data and DSE results were analyzed
      in 1734 consecutive patients undergoing DSE between 1989 and 1997.
      Seventy-four patients who underwent revascularization within 3 months of
      DSE and 1 patient lost to follow-up were excluded; the remaining 1659
      (median age, 62 years; range, 14 to 99 years) were followed up for 36
      months (range, 6 to 96 months). Wall motion abnormalities at rest and the
      presence and extent of stress-induced wall motion abnormalities (ischemia)
      were scored for each patient. Cardiac events were related to clinical and
      ECG data and DSE results. Four hundred twenty-eight cardiac events
      occurred in 366, documented cardiac death in 108 (total death, 247),
      nonfatal infarction in 128, and late revascularization in 192 patients. In
      a multivariable Cox proportional-hazards model, the ratio of documented
      cardiac death or (re)infarction was increased in the presence of
      stress-induced ischemia (hazard ratio, 3.3; 95% CI, 2.4 to 4.4) and
      extensive rest wall motion abnormalities (hazard ratio, 1.9; 95% CI, 1.3
      to 2.6). The number of ischemic segments was predictive for late cardiac
      events. A normal DSE carried a relatively good prognosis, with an annual
      event rate of cardiac death or infarction of 1.3% over a 5-year period.
      CONCLUSIONS--In a large group of patients, DSE has an added value for
      predicting late cardiac events during long-term follow-up, improving the
      separation between high- risk and very-low-risk patients.</description>
    </item> <item>
      <title>The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group (Article)</title>
      <link>http://repub.eur.nl/res/pub/9207/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Cardiovascular complications are the most important causes of
          perioperative morbidity and mortality among patients undergoing major
          vascular surgery. METHODS: We performed a randomized, multicenter trial to
          assess the effect of perioperative blockade of beta-adrenergic receptors
          on the incidence of death from cardiac causes and nonfatal myocardial
          infarction within 30 days after major vascular surgery in patients at high
          risk for these events. High-risk patients were identified by the presence
          of both clinical risk factors and positive results on dobutamine
          echocardiography. Eligible patients were randomly assigned to receive
          standard perioperative care or standard care plus perioperative
          beta-blockade with bisoprolol. RESULTS: A total of 1351 patients were
          screened, and 846 were found to have one or more cardiac risk factors. Of
          these 846 patients, 173 had positive results on dobutamine
          echocardiography. Fifty-nine patients were randomly assigned to receive
          bisoprolol, and 53 to receive standard care. Fifty-three patients were
          excluded from randomization because they were already taking a
          beta-blocker, and eight were excluded because they had extensive
          wall-motion abnormalities either at rest or during stress testing. Two
          patients in the bisoprolol group died of cardiac causes (3.4 percent), as
          compared with nine patients in the standard-care group (17 percent,
          P=0.02). Nonfatal myocardial infarction occurred in nine patients given
          standard care only (17 percent) and in none of those given standard care
          plus bisoprolol (P&lt;0.001). Thus, the primary study end point of death from
          cardiac causes or nonfatal myocardial infarction occurred in 2 patients in
          the bisoprolol group (3.4 percent) and 18 patients in the standard-care
          group (34 percent, P&lt;0.001). CONCLUSIONS: Bisoprolol reduces the
          perioperative incidence of death from cardiac causes and nonfatal
          myocardial infarction in high-risk patients who are undergoing major
          vascular surgery.</description>
    </item> <item>
      <title>Three-dimensional ultrasound study of carotid arteries before and after endarterectomy; analysis of stenotic lesions and surgical impact on the vessel (Article)</title>
      <link>http://repub.eur.nl/res/pub/8904/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND and PURPOSE: It has been proved that symptomatic patients with
          severe carotid stenosis benefit from endarterectomy. Currently used
          methods for quantitation of the severity of carotid stenosis have
          limitations, and the impact of endarterectomy on the operated region of
          carotid artery remains unknown. The purpose of this study was to examine
          the accuracy of a 3-D ultrasound system for quantitation of stenotic
          lesions and to evaluate changes in regional vessel volume and
          cross-sectional area after carotid endarterectomy. METHODS: We studied 14
          patients with both carotid angiography and 3-D ultrasound. Of 13 patients
          who underwent surgery, 12 were reexamined with 3-D ultrasound after
          surgery. The length and volume of 20 randomly selected plaques were
          measured from 3-D data sets. The severity of stenosis was quantified by
          3-D ultrasound using both a diameter method and an area method on
          cross-sectional views at the most stenotic site; the results were then
          compared with those from carotid angiography. The segmental vessel volume
          and average cross-sectional area of the operated artery both before and
          after endarterectomy were measured from 3-D ultrasound data. RESULTS: Good
          correlation was obtained between 3-D ultrasound and carotid angiography in
          quantitative analysis of carotid stenosis (SEE=12.4%, r=0.76, and mean
          difference=7.0+/-12.3% with the diameter method; SEE=10.5%, r=0.82, and
          mean difference=1.8+/-10.5% with the area method by 3-D ultrasound). 3-D
          ultrasound had excellent reproducibility and small intraobserver and
          interobserver variability in plaque length and volume measurements. No
          significant changes in segmental vessel volume and average cross-sectional
          area of the operated artery were observed after surgery in patients with
          suture closure. However, a significant increase in segmental vessel volume
          was obtained in patients with polyfluorethylene patches applied to the
          surgical opening of the artery. CONCLUSIONS: 3-D ultrasound can be used
          for both qualitative and quantitative analysis of plaques in the carotid
          artery and to detect and quantify significant carotid stenosis. Its
          volumetric potential has important clinical implications in serial
          follow-up studies for observing the progression or regression of stenotic
          lesions and for evaluating the outcome of interventional procedures such
          as endarterectomy or stent placement.</description>
    </item> <item>
      <title>Noninvasive diagnosis of coronary artery stenosis in women with limited exercise capacity: comparison of dobutamine stress echocardiography and 99mTc sestamibi single-photon emission CT (Article)</title>
      <link>http://repub.eur.nl/res/pub/8921/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVES: To compare the accuracy of dobutamine stress echocardiography
          (DSE) and simultaneous 99mTc sestamibi (MIBI) single-photon emission CT
          (SPECT) imaging for the diagnosis of coronary artery stenosis in women.
          PATIENTS: Seventy women with limited exercise capacity referred for
          evaluation of myocardial ischemia. METHODS: DSE (up to 40 microg/kg/min)
          was performed in conjunction with stress MIBI SPECT. Resting MIBI images
          were acquired 24 h after the stress test. Ischemia was defined as new or
          worsened wall motion abnormalities confirmed by DSE and as reversible
          perfusion defects confirmed by MIBI. Significant coronary artery disease
          was defined as &gt; or = 50% luminal diameter stenosis. RESULTS: DSE was
          positive for ischemia in 35 of 45 patients with coronary artery stenosis
          and in 2 of 25 patients without coronary artery stenosis (sensitivity =
          78% CI, 68 to 88; specificity = 92% CI, 85 to 99; and accuracy = 83% CI,
          74 to 92). A positive MIBI study for ischemia occurred in 29 patients with
          coronary artery stenosis and in 7 patients without coronary artery
          stenosis (sensitivity = 64% CI, 53 to 76; specificity = 72% CI, 61 to 83;
          and accuracy = 67% CI, 56 to 78 [p &lt; 0.05 vs DSE]). In the 59 vascular
          regions with coronary artery stenosis, the regional sensitivity of DSE was
          higher than MIBI (69% CI, 62 to 77 vs 51% CI, 42 to 59, p &lt; 0.05), whereas
          specificity in the 81 vascular regions without significant stenosis was
          similar (89% CI, 84 to 94 vs 88% CI, 82 to 93, respectively). CONCLUSION:
          DSE is a useful noninvasive method for the diagnosis of coronary artery
          stenosis in women and provides a higher overall and regional diagnostic
          accuracy than dobutamine MIBI SPECT in this particular population.</description>
    </item> <item>
      <title>Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test (Article)</title>
      <link>http://repub.eur.nl/res/pub/8927/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: Dobutamine stress testing is increasingly used for the
          diagnosis and functional evaluation of coronary artery disease. However,
          little is known about the safety and feasibility of this stress modality
          in diabetic patients. RESEARCH DESIGN AND METHODS: We studied the impact
          of diabetes on hemodynamic profile and on the safety and feasibility of
          dobutamine (up to 40 microg x kg(-1) x min(-1)) and atropine (up to 1 mg)
          stress echocardiography for the diagnosis of coronary artery disease in
          1,446 consecutive patients (aged 60+/-12 years, 962 men) with limited
          exercise capacity and suspected myocardial ischemia. Of these, 184
          patients were known to have IDDM or NIDDM. The test was considered
          feasible when 85% of the maximal heart rate and/or an ischemic end point
          (new or worsened wall motion abnormalities, ST segment depression, or
          angina) was achieved. RESULTS: No myocardial infarction or death occurred
          during the test. There was no significant difference between diabetic and
          nondiabetic patients with regard to heart rate increase during dobutamine
          stress echocardiography (58+/-25 vs. 61+/-24 beats/min), peak rate
          pressure product (18,400+/-3,135 vs. 18,048+/-4454), or the prevalence of
          hypotension (systolic blood pressure drop of &gt;40 mmHg) (7 vs. 5%),
          ventricular tachycardia (5.4 vs. 4.5%), and supraventricular tachycardia
          (3 vs. 4%) during the test. Dobutamine stress echocardiography was
          feasible in 92% of the diabetic patients and in 90% of the nondiabetic
          patients. Coronary angiography was performed in 55 diabetic and 240
          nondiabetic patients. Sensitivity, specificity, and accuracy of dobutamine
          stress echocardiography for the diagnosis of coronary artery disease in
          diabetic patients were 81, 85, and 82%. Those in nondiabetic patients were
          74, 87, and 77%, respectively (NS). CONCLUSIONS: Dobutamine stress
          echocardiography is a feasible method for the diagnosis of coronary artery
          disease in patients with limited exercise capacity with a comparable
          safety, feasibility, and accuracy in diabetic and nondiabetic patients.</description>
    </item> <item>
      <title>Variations of remodeling in response to left main atherosclerosis assessed with intravascular ultrasound in vivo. (Article)</title>
      <link>http://repub.eur.nl/res/pub/4971/</link>
      <pubDate>1997-12-01T00:00:00Z</pubDate>
      <description>Histopathologic studies have demonstrated that vessels enlarge to compensate for an increase in plaque burden; this has been confirmed in vivo using intravascular ultrasound (IVUS). The initial studies suggested a biphasic course of lesion formation with (1) preservation of lumen dimensions up to a plaque burden of approximately 40%, and (2) luminal narrowing as plaque burden further increases. In this study, we used IVUS and angiography to assess the extent of left main (LM) atherosclerosis in 107 patients undergoing catheter-based procedures of the left anterior descending or left circumflex coronary arteries. Using IVUS, atherosclerotic plaques were found in all LM arteries, but only 26 (24%) had varying degrees of luminal narrowing on the angiogram. Nevertheless, there was an inverse relation (r = −0.62, p &lt;0.0001) between the minimal lumen area and the plaque burden (i.e., plaque + media divided by total vessel area) that was not restricted to plaque burden values &gt;40% (or &gt;30%), but persisted at plaque burden values of 20% to 40%. In addition, LM arteries with a plaque burden &lt;40% had a similar total vessel area as did LM arteries with a plaque burden ≥40% (22.9 ± 6.1 vs 21.8 ± 4.8 mm2, p = 0.30). These data suggest that lumen dimensions may not be preserved even if plaque occupies no more than 20% to 40% of the total vessel area. Thus, there is more variation in remodeling response during earlier stages of plaque accumulation within the LM artery than is commonly suggested.</description>
    </item> <item>
      <title>Three-Dimensional Myocardial Perfusion Maps by Contrast Echocardiography (Article)</title>
      <link>http://repub.eur.nl/res/pub/4989/</link>
      <pubDate>1997-07-01T00:00:00Z</pubDate>
      <description>We evaluated the clinical applicability of a system for three-dimensional (3-D) display of a perfusion map following myocardial contrast echocardiography (MCE). The system was used in 12 patients (9 males and 3 females, mean age 52 ± 10 years) undergoing interventional treatment of chronic total coronary occlusion. In each patient three standard apical views were acquired at baseline with sonicated IopamidolR injections into the left coronary artery (LCA) and into the right coronary artery (RCA). Following successful recanalization of the occluded artery MCE was repeated. The patients tolerated the procedure well. Acquisition of three standard apical views provided sufficient information for the reconstruction of 3-D perfusion maps containing the 16 standard left ventricular (LV) segments. Side-by-side display of the perfusion maps obtained following LCA and RCA echocontrast injections allowed us to classify the myocardial segments (192) into three groups: (1) those supplied by one major artery (124); (2) those supplied by collaterals from contralateral or both major arteries (58); and (3) segments supplied by none of the major arteries (10). Decreased opacification was observed in 50 segments of group 2. Following successful intervention we were able to visualize the redistribution of blood flow delivered to the LV myocardium by each major coronary artery in 3-D format. We conclude that this 3-D approach, which can easily be performed with currently available ultrasound equipment, allows an estimate of the contribution of each major coronary artery to LV perfusion before and after coronary angioplasty.</description>
    </item> <item>
      <title>ECG-Gated Three-dimensional Intravascular Ultrasound (Article)</title>
      <link>http://repub.eur.nl/res/pub/4975/</link>
      <pubDate>1997-01-01T00:00:00Z</pubDate>
      <description>Background Automated systems for the quantitative analysis of three-dimensional (3D) sets of intravascular ultrasound (IVUS) images have been developed to reduce the time required to perform volumetric analyses; however, 3D image reconstruction by these nongated systems is frequently hampered by cyclic artifacts.

Methods and Results We used an ECG-gated 3D IVUS image acquisition workstation and a dedicated pullback device in atherosclerotic coronary segments of 30 patients to evaluate (1) the feasibility of this approach of image acquisition, (2) the reproducibility of an automated contour detection algorithm in measuring lumen, external elastic membrane, and plaque+media cross-sectional areas (CSAs) and volumes and the cross-sectional and volumetric plaque+media burden, and (3) the agreement between the automated area measurements and the results of manual tracing. The gated image acquisition took 3.9±1.5 minutes. The length of the segments analyzed was 9.6 to 40.0 mm, with 2.3±1.5 side branches per segment. The minimum lumen CSA measured 6.4±1.7 mm2, and the maximum and average CSA plaque+media burden measured 60.5±10.2% and 46.5±9.9%, respectively. The automated contour-detection required 34.3±7.3 minutes per segment. The differences between these measurements and manual tracing did not exceed 1.6% (SD&lt;6.8%). Intraobserver and interobserver differences in area measurements (n=3421; r=.97 to.99) were &lt;1.6% (SD&lt;7.2%); intraobserver and interobserver differences in volumetric measurements (n=30; r=.99) were &lt;0.4% (SD&lt;3.2%).

Conclusions ECG-gated acquisition of 3D IVUS image sets is feasible and permits the application of automated contour detection to provide reproducible measurements of the lumen and atherosclerotic plaque CSA and volume in a relatively short analysis time.</description>
    </item> <item>
      <title>Comparison of Coronary Luminal Quantification Obtained From Intracoronary Ultrasound and Both Geometric and Videodensitometric Quantitative Angiography Before and After Balloon Angioplasty and Directional Atherectomy (Article)</title>
      <link>http://repub.eur.nl/res/pub/4986/</link>
      <pubDate>1997-01-01T00:00:00Z</pubDate>
      <description>Background Debate exists regarding the relationship between angiographic and intracoronary ultrasound (ICUS) measurements of minimal luminal cross-sectional area after coronary intervention. We investigated this and the factors that may influence it by using ICUS and quantitative angiography.

Methods and Results Patients who underwent successful balloon angioplasty (n=100) or directional atherectomy (n=50) were examined by using ICUS and quantitative angiography (edge-detection [ED] and videodensitometry [VID]) before and after intervention. Luminal damage postintervention was qualitatively graded into three categories based on angiographic results (smooth lumen, haziness, or dissection). Correlation of minimal luminal cross-sectional area measurements by ICUS and ED was .59 before and .47 after balloon angioplasty. Correlation between ICUS and VID was .50 before and .63 after balloon angioplasty. Postintervention, the difference between ICUS and VID was less than the difference between ICUS and ED (P&lt;.01). Additionally, the correlation was .74 between ICUS and ED measurements and .78 between ICUS and VID measurements in the smooth lumen group, .46 and .63, respectively, in the presence of haziness, and .26 and .46, respectively, in lesions with dissection. Similar results were obtained after directional atherectomy: the agreement between ICUS and quantitative angiography deteriorated according to the degree of vessel damage, but less so with VID than ED.

Conclusions Complex morphological changes induced by intervention may contribute to discordance between the two quantitative imaging techniques. In the absence of ICUS, VID may be a complementary technique to ED in lesions with complex morphology after balloon angioplasty and directional atherectomy.</description>
    </item> <item>
      <title>Site-Specific Intracoronary Heparin Delivery in Humans After Balloon Angioplasty (Article)</title>
      <link>http://repub.eur.nl/res/pub/4988/</link>
      <pubDate>1997-01-01T00:00:00Z</pubDate>
      <description>Background Demonstration and quantification of site-specific intracoronary administration of compounds has been confined thus far to the experimental animal laboratory. The aim of this study was to describe a scintigraphic method to demonstrate site-specific intracoronary drug delivery in humans. The methods allow on-line visualization and off-line quantification of site-specifically infused -emitting compounds.

Methods and Results In 12 patients after balloon angioplasty, 99mTc-labeled heparin was administered at the site of dilatation by use of a coil balloon. Both the infusion period and the washout period after the end of infusion were monitored with a -camera. A curve of counts per pixel as a function of time was derived that showed an accumulation phase during infusion followed by a washout phase after the end of infusion. Both phases were fitted by regression analysis and showed a linear accumulation pattern and a biexponential washout pattern. After correction for background counts, 99mTc decay, and body attenuation, peak heparin amount and regional bioavailability were calculated. Peak amount was defined as the initial point of the slow washout component of the biexponential curve (elimination component), and regional bioavailability was defined as the area under the curve of accumulation and washout phase. Half-life and retention time, defined as seven half-lives, were obtained by use of the elimination component after correction for 99mTc decay. Mean peak delivered amount was 45±44 IU (236±228 µg), corresponding to an efficiency of delivery ranging from 1% to 8% of the totally infused dose. Total regionally bioavailable heparin reached 244±194 IU·h (1.28±1.01 mg·h). Retention time varied from 12 to 90 hours (mean, 50:33±22:50 hours:minutes).

Conclusions Site-specific intracoronary heparin delivery after angioplasty by means of the coil balloon was demonstrated in humans, and regional pharmacokinetics was quantified by use of a radioisotopic technique.</description>
    </item> <item>
      <title>Simpson's rule for the volumetric ultrasound assessment of atherosclerotic coronary arteries: a study with ECG-gated three-dimensional intravascular ultrasound. (Article)</title>
      <link>http://repub.eur.nl/res/pub/4992/</link>
      <pubDate>1997-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Volumetric intravascular ultrasound (IVUS) assessment provides complementary information on atherosclerotic plaques. The volumes can be calculated by applying Simpson's rule to cross-sectional area data of multiple IVUS images, acquired with a fixed sample spacing, which is the distance (along the vessel's axis) between two images. OBJECTIVE: To evaluate the effect of different sample spacings on the results of volumetric IVUS measurements. METHODS: A stepwise electrocardiographically gated IVUS image-acquisition and automated three-dimensional analysis approach was applied to 26 patients. Twenty-eight coronary segments with mild-to-moderate coronary atherosclerosis were examined. Volumetric measurements of five images per mm (i.e. sample spacing 0.2 mm), representing a complete scanning of the coronary segment, were considered the optimal standard, against which volumetric measurements of three, one, and one-half images per mm (i.e. larger sample spacings) were compared. RESULTS: The lumen, total vessel, and plaque volumes obtained with five images per mm were 183.3 +/- 2.8, 350.6 +/- 141.6, and 167.3 +/- 89.2 mm3. There was an excellent correlation (r = 0.99, P &lt; 0.001) between these data and volumetric measurements with larger sample spacings. The volumetric measurements with larger sample spacings differed on average only by a little (&lt; 0.7%) from the optimal standard measurements. However, a relatively small, but significant, increase in SD of these differences was associated with the wider sample spacings (&lt; 3.6%, P &lt; 0.05). CONCLUSIONS: The width of the sample spacing has a relatively small but significant impact on the variability of volumetric intravascular ultrasound measurements. This should be considered when designing future volumetric studies. The electrocardiographically gated acquisition of five IVUS images per mm axial length during a stepwise transducer pull-back is an ideal approach, particularly when addressing with IVUS volumetric changes that are assumed small, such as those expected in studies of the progression and regression of atherosclerosis.</description>
    </item> <item>
      <title>Relation between ST segment elevation during dobutamine stress test and myocardial viability after a recent myocardial infarction (Article)</title>
      <link>http://repub.eur.nl/res/pub/8657/</link>
      <pubDate>1997-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: To assess the relation between ST segment elevation during the
          dobutamine stress test and late improvement of function after acute Q wave
          myocardial infarction. PATIENTS AND DESIGN: 70 patients were studied a
          mean (SD) 8 (3) days after acute myocardial infarction with high dose
          dobutamine-atropine stress echocardiography and a follow up echocardiogram
          at 85 (10) days. A score model based on 16 segments and four grades was
          used to assess left ventricular function. Functional improvement was
          defined as a reduction of wall motion score &gt; or = 1 in &gt; or = 1 segments
          at follow up. INTERVENTION: Myocardial revascularisation was performed in
          23 patients (33%) before follow up studies. RESULTS: ST segment elevation
          occurred in 40 patients (57%). Late functional improvement occurred in 35
          patients (50%). Functional improvement was more common in patients with ST
          segment elevation (68% v 30%, P &lt; 0.005) and they had a higher mean (SD)
          number of improved segments at follow up (1.9 (2.2) v 0.5 (1.1), P &lt;
          0.005). The wall motion score index decreased between baseline and follow
          up in patients with ST segment elevation (1.54 (0.50) v 1.48 (0.43), P &lt;
          0.05) but not in patients without ST segment elevation (1.39 (0.60) v 1.45
          (0.47)). The accuracy of ST segment elevation for the prediction of
          functional improvement was similar to that of low dose dobutamine
          echocardiography in patients with anterior infarction (80% v 83%) and in
          patients who underwent revascularisation (78% v 83% respectively).
          CONCLUSION: In patients with a recent Q wave myocardial infarction,
          dobutamine-induced ST segment elevation is a valuable marker of myocardial
          viability particularly when the test is performed without or with
          suboptimal echocardiographic imaging.</description>
    </item> <item>
      <title>Computerized assessment of coronary lumen and atherosclerotic plaque dimensions in three-dimensional intravascular ultrasound correlated with histomorphometry. (Article)</title>
      <link>http://repub.eur.nl/res/pub/5003/</link>
      <pubDate>1996-01-01T00:00:00Z</pubDate>
      <description>Intravascular ultrasound (IVUS), which depicts both lumen and plaque, offers the potential to improve on the limitations of angiography for the assessment of the natural history of atherosclerosis and progression or regression of the disease. To facilitate measurements and increase the reproducibility of quantitative IVUS analyses, a computerized contour detection system was developed that detects both the luminal and external vessel boundaries in 3-dimensional sets of IVUS images. To validate this system, atherosclerotic human coronary segments (n = 13) with an area obstruction ≥40% (40% to 61%) were studied in vitro by IVUS. The computerized IVUS measurements (areas and volumes) of the lumen, total vessel, plaque-media complex, and percent obstruction were compared with findings by manual tracing of the IVUS images and of the corresponding histologic cross sections obtained at 2-mm increments (n = 100). Both area and volume measurements by the contour detection system agreed well with the results obtained by manual tracing, showing low mean between-method differences (−3.7% to 0.3%) with SDs not exceeding 6% and high correlation coefficients (r = 0.97 to 0.99). Measurements of the lumen, total vessel, plaque-media complex, and percent obstruction by the contour detection system correlated well with histomorphometry of areas (r = 0.94, 0.88, 0.80, and 0.88) and volumes (r = 0.98, 0.91, 0.83, and 0.91). Systematic differences between the results by the contour detection system and histomorphometry (29%, 13%, −9%, and −22%, respectively) were found, most likely resulting from shrinkage during tissue fixation. The results of this study indicate that this computerized IVUS analysis system is reliable for the assessment of coronary atherosclerosis in vivo.</description>
    </item> <item>
      <title>Akinesis becoming dyskinesis during dobutamine stress echocardiography. A predictor of poor functional recovery after surgical revascularization (Article)</title>
      <link>http://repub.eur.nl/res/pub/8613/</link>
      <pubDate>1996-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Akinesis becoming dyskinesis at high-dose dobutamine stress
          echocardiography (DSE) has been disregarded as a marker of myocardial
          ischemia. However, to our knowledge, the relationship between this pattern
          and myocardial viability has not been assessed. METHODS: We studied 42
          patients with myocardial infarction who underwent DSE (up to 40
          micrograms/kg/min) before coronary artery bypass surgery, and resting
          echocardiogram 3 months after surgery. Viability in akinetic segments was
          considered to be present if systolic thickening occurred with low-dose
          dobutamine (LDD). RESULTS: During high-dose DSE, dyskinesis occurred in 35
          of the 164 akinetic segments (group A). The remaining 129 segments
          comprised group B. Segments of group B had a higher prevalence of
          viability pattern with LDD (18% vs 0%; p &lt; 0.01) and a higher prevalence
          of functional improvement (20% vs 0%; p &lt; 0.005) compared with group A. In
          absence of viability pattern with LDD, postoperative improvement occurred
          in 10% of segments in group B and in none of segments in group A,
          resulting in a higher negative predictive value of LDD in group A vs B
          (100% vs 90%; p &lt; 0.05). CONCLUSION: The phenomenon of akinesis becoming
          dyskinesis with high-dose DSE is associated with absence of viability
          pattern with LDD and poor functional outcome after surgical
          revascularization. Observation of this pattern provides additional data to
          those obtained only with LDD echocardiography.</description>
    </item> <item>
      <title>Ischemia-Related Lesion Characteristics in Patients With Stable or Unstable Angina (Article)</title>
      <link>http://repub.eur.nl/res/pub/5071/</link>
      <pubDate>1995-01-01T00:00:00Z</pubDate>
      <description>Background Postmortem-derived findings support the common beliefs that lipid-rich coronary plaques with a thin, fibrous cap are prone to rupture and that rupture and superimposed thrombosis are the primary mechanisms causing acute coronary syndromes. In vivo imaging with intracoronary techniques may disclose differences in the characterization of atherosclerotic plaques in patients with stable or unstable angina and thus may provide clues to which plaques may rupture and whether rupture and thrombosis are active.

Methods and Results We assessed the characteristics of the ischemia-related lesions with coronary angiography and intracoronary angioscopy and determined their compositions with intracoronary ultrasound in 44 patients with unstable and 23 patients with stable angina. The angiographic images were classified as noncomplex (smooth borders) or complex (irregular borders, multiple lesions, thrombus). Angioscopic images were classified as either stable (smooth surface) or thrombotic (red thrombus). The ultrasound characteristics of the lesion were classified as poorly echo-reflective, highly echo-reflective with shadowing, or highly echo-reflective without shadowing. There was a poor correlation between clinical status and angiographic findings. An angiographic complex lesion (n=33) was concordant with unstable angina in 55% (24 of 44); a noncomplex lesion (n=34) was concordant with stable angina in 61% (14 of 23). There was a good correlation between clinical status and angioscopic findings. An angioscopic thrombotic lesion (n=34) was concordant with unstable angina in 68% (30 of 44); a stable lesion (n=33) was concordant with stable angina in 83% (19 of 23). The ultrasound-obtained composition of the plaque was similar in patients with unstable and stable angina.

Conclusions Angiography discriminates poorly between lesions in stable and unstable angina. Angioscopy demonstrated that plaque rupture and thrombosis were present in 17% of stable angina and 68% of unstable angina patients. Currently available ultrasound technology does not discriminate stable from unstable plaques.</description>
    </item> <item>
      <title>Three dimensional reconstruction of cross sectional intracoronary ultrasound: clinical or research tool? (Article)</title>
      <link>http://repub.eur.nl/res/pub/5080/</link>
      <pubDate>1995-01-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Advantages and limitations of intracoronary ultrasound for the assessment of vascular dimensions (Article)</title>
      <link>http://repub.eur.nl/res/pub/4583/</link>
      <pubDate>1994-02-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Complicaties kort na percutane transluminale angioplastiek of na coronariachirurgie bij 183 vergelijkbare patienten met een meervatscoronaria-aandoening (Article)</title>
      <link>http://repub.eur.nl/res/pub/4602/</link>
      <pubDate>1994-01-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Quantitative coronary angiography in the estimation of the functional significance of coronary stenosis: correlations with dobutamine-atropine stress test (Article)</title>
      <link>http://repub.eur.nl/res/pub/4603/</link>
      <pubDate>1994-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVES. The purpose of this study was to determine the predictive value of quantitative coronary angiography in the assessment of the functional significance of coronary stenosis as judged from the development of left ventricular wall motion abnormalities during dobutamine-atropine stress echocardiography. BACKGROUND. Coronary angiography is the reference method for assessment of the accuracy of noninvasive diagnostic imaging techniques to detect the presence of significant coronary stenosis. However, use of arbitrary cutoff criteria for the interpretation of angiographic data may considerably influence the true diagnostic accuracy of the technique investigated. METHODS. Thirty-four patients without previous myocardial infarction and with single-vessel coronary stenosis were studied with both quantitative angiography and dobutamine-atropine stress echocardiography. Two different techniques of quantitative angiographic analysis--edge detection and videodensitometry--were used for measurement of minimal lumen diameter, percent diameter stenosis and percent area stenosis. Two-dimensional echocardiographic images were collected during incremental doses of intravenous dobutamine and later analyzed using a 16-segment left ventricular model. Angiographic cutoff criteria were derived from receiver-operating curves to define the functional significance of coronary stenosis on the basis of dobutamine-atropine stress echocardiography. RESULTS. The angiographic cutoff values with the best predictive value for the development of left ventricular wall motion abnormalities during dobutamine-atropine stress echocardiography were minimal lumen diameter of 1.07 mm, percent diameter stenosis of 52% and percent area stenosis of 75%. Minimal lumen diameter was found to have the best predictive value for a positive dobutamine stress test (odds ratio 51, sensitivity 94%, specificity 75%). CONCLUSIONS. Automated quantitative angiographic measurement of minimal lumen diameter is a practical and useful index for determining both the anatomic and functional significance of coronary stenosis, and a value of 1.07 mm is the best predictor for a positive dobutamine stress test.</description>
    </item> <item>
      <title>Intracoronary ultrasound and angioscopic imaging facilitating the understanding and treatment of post-infarction angina (Article)</title>
      <link>http://repub.eur.nl/res/pub/4610/</link>
      <pubDate>1994-01-01T00:00:00Z</pubDate>
      <description>We report on the use of intravascular ultrasound, coronary angioscopy and on-line quantitative angiography in an unstable patient soon after myocardial infarction. Combined intracoronary imaging made it possible to solve the therapeutic problem posed by an unusual angiographic appearance secondary to intracoronary thrombolysis during coronary recanalization. The pathological validation of the observations performed with angioscopy and intravascular ultrasound was made possible with the concomitant use of directional atherectomy.</description>
    </item> <item>
      <title>Three-dimensional reconstruction of intracoronary ultrasound images. Rationale, approaches, problems, and directions (Miscellaneous)</title>
      <link>http://repub.eur.nl/res/pub/4628/</link>
      <pubDate>1994-01-01T00:00:00Z</pubDate>
      <description>Although intracoronary ultrasonography allows detailed tomographic imaging of the arterial wall, it fails to provide data on the structural architecture and longitudinal extent of arterial disease. This information is essential for decision making during therapeutic interventions. Three-dimensional reconstruction techniques offer visualization of the complex longitudinal architecture of atherosclerotic plaques in composite display. Progress in computer hardware and software technology have shortened the reconstruction process and reduced operator interaction considerably, generating three-dimensional images with delineation of mural anatomy and pathology. The indications for intravascular ultrasonography will grow as the technique offers the unique capability of providing ultrasonic histology of the arterial wall, and the need for a three-dimensional display format for comprehensive analysis is increasingly recognized. Consequently, three-dimensional imaging is being rapidly implemented in the catheterization laboratories for guidance of intracoronary interventions and detailed assessment of their results. However exciting the prospects may be, three-dimensional reconstructions at present remain partially artificial because the true spatial position of the imaging catheter tip is not recorded, and shifts in its location and curves of the arterial lumen result in pseudoreconstructions rather than true reconstructions. In this report, we address the principles of three-dimensional reconstruction with a critical review of its limitations. Potential solutions for refinement of this exciting imaging modality are presented.</description>
    </item> <item>
      <title>Limitation of the zero crossing detector in the analysis of intracoronary Doppler: a comparison with fast fourier transform analysis of basal, hyperemic, and transstenotic blood flow velocity measurements in patients with coronary artery disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/4497/</link>
      <pubDate>1993-01-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Intracoronary blood flow velocity and transstenotic pressure gradient using sensor-tip pressure and doppler guidewires: a new technology for the assessment of stenosis severity in the Catheterization Laboratory (Article)</title>
      <link>http://repub.eur.nl/res/pub/4502/</link>
      <pubDate>1993-01-01T00:00:00Z</pubDate>
      <description>In a patient undergoing percutaneous balloon angioplasty of a stenotic proximal right coronary artery the transstenotic pressure gradient was measured using a 0.018" guidewire with a distal optical microsensor. Blood flow velocity was measured proximal to the stenosis using a 0.018" Doppler guidewire. Transstenotic pressure gradient and blood flow velocity were measured in baseline conditions and after intracoronary injection of 12.5 mg of papaverine. Coronary blood flow was calculated from the measured blood flow velocity and the corresponding cross-sectional area. The measured pressure gradients were compared with the values derived from the stenosis geometry assessed with quantitative coronary angiography (automated edge detection measurements in two orthogonal views, assuming an elliptical cross-sectional area). The measured transstenotic pressure gradient was 15 mm Hg in baseline conditions and 42 mm Hg at the peak effect of the papaverine injection. A 50% flow velocity increase was observed at peak hyperemia (time-averaged maximal flow velocity = 30 cm/s before and 45 cm/s after papaverine). The transstenotic pressure gradient calculated from the measured stenosis geometry was 20 mm Hg and 42 mm Hg in baseline and hyperemic conditions, respectively. The combined use of a pressure and a Doppler guidewire provides a complete assessment of the transstenotic pressure/coronary flow velocity relation at rest and after pharmacologically induced hyperemia and allows the characterization of stenosis hemodynamics and functional severity.</description>
    </item> <item>
      <title>The angle of incidence of the ultrasonic beam: a critical factor for the image quality in intravascular ultrasonography (Article)</title>
      <link>http://repub.eur.nl/res/pub/4503/</link>
      <pubDate>1993-01-01T00:00:00Z</pubDate>
      <description>The effects of the angle of incidence of the ultrasound beam on the image quality were studied in 21 pressurized arterial specimens examined with a 30 MHz intravascular ultrasonographic catheter. When the ultrasonographic catheter was in an eccentric position in the vessel lumen, the videodensity of the segments of the vessel wall with the least favorable angle of interrogation (a shift of 49 +/- 6 degrees from the tangent to the tissue surface) was 27% +/- 19% lower than the videodensity measured with the catheter in the center of the lumen. When the catheter was placed in a position that was not parallel to the long axis of the vessel, a further decrease was observed, especially in the vessel wall opposite the position of the catheter. An artificial dissection was induced in eight specimens. Dropouts that involved the dissection plane and the underlying structures were produced with positions of the echographic catheter inducing a narrow angle between ultrasound beam and dissection plane. These experimentally induced artifacts were compared with similar findings from the in vivo evaluation of peripheral and coronary arteries. The angle of incidence of the ultrasound beam is a major determinant of the image quality in intravascular ultrasonography. Angle-dependent artifacts occur with eccentric and noncoaxial positions of the ultrasonographic catheter and, in particular, with imaging of large intraluminal dissections. Awareness of this problem may prevent image misinterpretation and has relevance for future improvement of catheter technology and design.</description>
    </item> <item>
      <title>Maximal blood flow velocity in severe coronary stenosis measured with a doppler guidewire. Limitations for the application of the continuity equation in the assessment of stenosis severity (Article)</title>
      <link>http://repub.eur.nl/res/pub/4506/</link>
      <pubDate>1993-01-01T00:00:00Z</pubDate>
      <description>In vitro and animal experiments have shown that the severity of coronary stenoses can be assessed using the continuity equation if the maximal blood flow velocity of the stenotic jet is measured. The large diameter and the low range of velocities measurable without frequency aliasing with the conventional intracoronary Doppler catheters precluded the clinical application of this method for hemodynamically significant coronary stenoses in humans. This article reports the results obtained using a 12 MHz steerable angioplasty guidewire in a consecutive series of 52 patients undergoing percutaneous coronary angioplasty (61 coronary stenoses). The ratio between coronary flow velocity in a reference segment and in the stenosis was used to estimate the percent cross-sectional area stenosis. A Doppler recording suitable for quantitation was obtained in the stenotic segment in only 10 of 61 arteries (16%). The time-averaged peak velocity increased from 15 +/- 5 to 115 +/- 26 cm/sec from the reference normal segment to the stenosis. Volumetric coronary flow calculated from the product of mean flow velocity and cross-sectional area was similar in the stenosis and in the reference segment (33.2 +/- 14.9 vs 33.5 +/- 17.0 mL/min, respectively, difference not significant). The percent cross-sectional area stenosis and minimal luminal cross-sectional area derived from the Doppler velocity measurements using the continuity equation and calculated with quantitative angiography were also similar (Doppler, 86.7 +/- 5.1% and 1.00 +/- 0.48 mm2; quantitative angiography, 85.9 +/- 7.9% and 1.02 +/- 0.50 mm2).(ABSTRACT TRUNCATED AT 250 WORDS)</description>
    </item> <item>
      <title>Intravascular ultrasound (Article)</title>
      <link>http://repub.eur.nl/res/pub/4516/</link>
      <pubDate>1993-01-01T00:00:00Z</pubDate>
      <description>--</description>
    </item> <item>
      <title>How to assess regression of the atherosclerotic plaque (Article)</title>
      <link>http://repub.eur.nl/res/pub/4523/</link>
      <pubDate>1993-01-01T00:00:00Z</pubDate>
      <description>--</description>
    </item> <item>
      <title>La relation instantanée pression-vélecité du flux coronaire, alternative à la mesure de la réserve coronaire: étude de faisabilité et reproductibilité de la méthode (Article)</title>
      <link>http://repub.eur.nl/res/pub/4527/</link>
      <pubDate>1993-01-01T00:00:00Z</pubDate>
      <description>Animal experimentation has shown that the instantaneous pressure-velocity of coronary blood flow in the hyperaemic phase has a linear relationship. The slope of this regression evaluates coronary reserve independently of haemodynamic variables and the X-intercept (zero flow pressure or Pf = 0) determines the intra-myocardial back pressure which could influence the regulation of coronary flow. The object of this study was to evaluate the instantaneous pressure-velocity relationship of coronary flow in clinical practice and to analyse the reproducibility of this parameter. Forty-nine patients were divided into two groups, depending on whether their coronary arteries were angiographically normal (n = 34) or atheromatous with stenosis &gt; or = 35% of the reference diameter (n = 15). Recordings of coronary flow velocity were made with a Doppler transducer mounted on a 0.018 inch guide wire. The slope of the diastolic linear segment of the pressure-velocity relationship was determined at the peak of papaverine-induced vasodilation from 4 consecutive cycles by a regression analysis. The pressure value at 0 flow was obtained by extrapolation of the regression slope to the axis of aortic perfusion pressure. A good quality spectral recording allowing reliable analysis of the velocity profile was obtained in 88% of cases (44/49). The high values of the correlation coefficient observed with each measurement of the slope confirm the applicability of linear regression analysis to the pressure-velocity relationship. The slope of the pressure-velocity relationship was significantly lower in patients with coronary stenosis (1.7 +/- 0.7 cm/s/mmHg in normal vessels versus 0.7 +/- 0.3 cm/s/mmHg in stenotic arteries, p &lt; 10(-4)), and, similarly, the pressure at zero flow was also reduced (36.9 +/- 16 mmHg versus 25.5 +/- 12 mmHg, p = 0.03). A statistically significant correlation was observed between the slope values and coronary flow reserve but no correlation was demonstrated between the slope and intraluminal surface area of angiographically normal coronary arteries or the slope and degree of stenosis of atheromatous vessels. The linear regression slope and the pressure at zero flow were lower when the pressure-velocity relationship was measured during long diastolic periods induced by the injection of adenosine. In addition, the curvilinear appearances of the pressure-velocity relationship observed during these long periods suggest that the linear regression model is not applicable throughout the whole range of pressures and velocities, especially for the lowest values.(ABSTRACT TRUNCATED AT 400 WORDS)</description>
    </item> <item>
      <title>Restenosis after coronary angioplasty: the paradox of increased lumen diameter and restenosis (Article)</title>
      <link>http://repub.eur.nl/res/pub/4445/</link>
      <pubDate>1992-01-01T00:00:00Z</pubDate>
      <description>Restenosis after coronary angioplasty is the single complication that most limits this revascularization procedure in clinical practice. The process is largely unpredictable and the lesion-related factors predisposing to restenosis are poorly understood, with little consensus in published reports. In this study using detailed quantitative angiographic measurements to assess 490 lesions, the simple lesion characteristics associated with restenosis were defined and the relation to the restenosis process documented. Restenosis was defined as an absolute deterioration in the minimal lumen diameter by greater than or equal to 0.72 mm, a criterion based on the 95% confidence intervals for repeat angiographic measurements. This was chosen in an attempt to separate spurious changes due to a poor angiographic result and the variability of angiographic measurements from significant changes due to the restenosis process. The principal determinants of restenosis were found to be a large improvement in the minimal lumen diameter at the time of dilation (1.13 mm for the restenosis group compared with 0.86 mm for the no restenosis group [p less than 0.0001]) and an optimal postangioplasty result (minimal lumen diameter 2.28 mm in the restenosis group compared with 2.05 mm [p less than 0.001] in the no restenosis group, corresponding to a 25% and a 30% diameter stenosis, respectively [p less than 0.0001]). These observations reported for the first time suggest that the distinction needs to be made between a "clinical restenosis" of greater than or equal to 50% diameter stenosis and the "restenosis process" as measured by the absolute changes occurring during and after angioplasty.(ABSTRACT TRUNCATED AT 250 WORDS)</description>
    </item> <item>
      <title>Changes in left ventricular function and wall thickness in heart transplant recipients and their relation to acute rejection: an assessment by digitised M mode echocardiography (Article)</title>
      <link>http://repub.eur.nl/res/pub/5443/</link>
      <pubDate>1992-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE--Assessment of changes in left ventricular diastolic function and wall thickness after heart transplantation to verify whether these changes predicted acute rejection assessed by endomyocardial biopsy. DESIGN--Follow up according to a predefined protocol of consecutive patients from the first week after transplantation. SETTING--Heart transplantation unit of the Thoraxcentre, University Hospital Rotterdam Dijkzigt, The Netherlands. PATIENTS--All 32 patients undergoing orthotopic heart transplantation from 1 January 1989 to 31 March 1990 were examined. Two were excluded from the analysis. Patients were treated with cyclosporin and low dose steroids. MAIN OUTCOME MEASURES--Data obtained by digitised M mode echocardiography were compared with the results of endomyocardial biopsy (Billingham classification). Mean values for left ventricular wall thickness, internal dimension, and their standardised rates of change and fractional shortening were determined from 4-6 consecutive expiratory beats. Mean values and individual trends during follow up were also investigated for each ultrasound variable. The results of these average values were compared with values in a group of 10 healthy volunteers. RESULTS--Median follow-up was 177 days (range 10-399). Two hundred and sixty three consecutive M mode studies were examined in relation to concurrent biopsy results. No significant differences were observed between the ultrasound variables at the time of moderate acute rejection (Billingham class 2, n = 37) and other biopsy classes (n = 226). Nor did changes in individual patients predict (moderate) acute rejection episodes. Twenty six of the 30 patients had an abnormal (slow) left ventricular relaxation pattern throughout follow up. CONCLUSIONS--Digitised left ventricular M mode echocardiography did not predict the presence of acute rejection. In most patients there was a persistent slow left ventricular relaxation pattern.</description>
    </item> <item>
      <title>Quantitative angiography after directional coronary atherectomy (Article)</title>
      <link>http://repub.eur.nl/res/pub/4421/</link>
      <pubDate>1991-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: To assess by quantitative analysis the immediate angiographic results of directional coronary atherectomy. To compare the effects of successful atherectomy with those of successful balloon dilatation in a series of patients with matched lesions. DESIGN--Case series. SETTING--Tertiary referral centre. PATIENTS--62 patients in whom directional coronary atherectomy was attempted between 7 September 1989 and 31 December 1990. INTERVENTIONS--Directional coronary atherectomy. MAIN OUTCOME MEASURES--Increase in minimal luminal diameter of coronary artery segment. RESULTS--Angiographic success on the basis of intention to treat was obtained in 54 patients (87%). In four patients the lesion could not be crossed by the atherectomy device; all four had an uneventful conventional balloon angioplasty. Four of the 58 patients who underwent atherectomy were subsequently referred for coronary bypass surgery because of failure or complications; three of them sustained a transmural infarction. In the successful cases, coronary atherectomy resulted in an increase in the minimal luminal diameter from 1.1 mm to 2.5 mm with a concomitant decrease of the diameter stenosis from 62% to 22%. In the subset of 37 patients in which the changes induced were compared with conventional balloon angioplasty atherectomy increased the minimal luminal diameter more than balloon angioplasty (1.6 v 0.8 mm; p less than 0.0001). Conventional histology showed media or adventitia in 26% of the atherectomy specimens. In hospital complications occurred in six patients who had undergone a successful procedure: two transmural infarctions, two subendocardial infarctions, one transient ischaemia attack, and one death due to delayed rupture of the atherectomised vessel. All patients were clinically evaluated at one and six months. One patient had persisting angina (New York Heart Association class II), one patient sustained a myocardial infarction, one patient underwent a percutaneous transluminal coronary angioplasty for early restenosis, and one patient underwent coronary bypass surgery because of a coronary aneurysm formation. At six months 80% (36/47) of the patients were symptom free. CONCLUSIONS--Coronary atherectomy achieved a better immediate angiographic result than balloon angioplasty; however, in view of the complication rate in this preliminary series, which may be related to a learning curve, a randomised study is needed to show whether this procedure is as safe as a conventional balloon angioplasty.</description>
    </item> <item>
      <title>Cyclic changes of blood echogenicity in high-frequency ultrasound (Article)</title>
      <link>http://repub.eur.nl/res/pub/4438/</link>
      <pubDate>1991-01-01T00:00:00Z</pubDate>
      <description>Ultrasound images from human arteries obtained in vivo with an intravascular 30 MHz ultrasound imaging device show that blood echogenicity changes during the cardiac cycle. Quantitative measurements of blood echogenicity during the cardiac cycle suggest that these variations may be related to changes in the state of erythrocyte aggregation, which are induced by varying shear rate.</description>
    </item> <item>
      <title>Thrombocythemia and coronary artery disease (Miscellaneous)</title>
      <link>http://repub.eur.nl/res/pub/5427/</link>
      <pubDate>1991-01-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Recovery of regional myocardial dysfunction after successful coronary angioplasty early after a non-Q wave myocardial infarction (Article)</title>
      <link>http://repub.eur.nl/res/pub/4384/</link>
      <pubDate>1990-01-01T00:00:00Z</pubDate>
      <description>More aggressive therapy has been suggested for patients who have a non-Q wave myocardial infarction (MI) because of the frequency of subsequent unstable angina, recurrent MI, and high mortality rate compared to patients with Q wave MI. The present study was undertaken to investigate the effect of coronary angioplasty on regional myocardial function of the infarct zone in patients with angina early after a non-Q wave MI. The study population consisted of 36 patients undergoing successful coronary angioplasty within 30 days of a non-Q wave MI, in whom sequential left ventricular angiograms of adequate quality were obtained before the initial procedure and at follow-up angiography. The global ejection fraction increased significantly from 60 +/- 9% to 67 +/- 6% (p = 0.0003). This significant increase in the global ejection fraction was primarily due to a significant improvement in the regional myocardial function of the infarct zone. The results of the present study show not only that ischemic attacks early after a non-Q wave MI may lead to prolonged regional myocardial dysfunction but more important that this depressed myocardium has the potential to achieve normal contraction after successful coronary angioplasty.</description>
    </item> <item>
      <title>A comparison of two methods to measure coronary flow reserve in the setting of coronary angioplasty: intracoronary blood flow velocity measurements with a Doppler catheter, and digital subtraction cineangiography (Article)</title>
      <link>http://repub.eur.nl/res/pub/4331/</link>
      <pubDate>1989-01-01T00:00:00Z</pubDate>
      <description>Intracoronary blood flow velocity measurements with a Doppler balloon catheter and the radiographic assessment of myocardial perfusion with contrast media, before and after the intracoronary administration of papaverine, have previously been used to investigate regional coronary flow reserve. In the present study we applied both techniques in 21 patients to measure coronary flow reserve in the setting of coronary angioplasty. Pre-angioplasty (N = 14) and post-angioplasty (N = 19) measurements of coronary flow reserve were obtained by digital subtraction cineangiography in the myocardial region supplied by the dilated coronary artery, and with the Doppler probe in the proximal part of the dilated vessel. The reactive hyperaemia following the final balloon inflation was recorded with the Doppler balloon catheter still positioned across the stenotic lesion. Coronary stenosis geometry was quantified with the Cardiovascular Angiography Analysis System. When the epicardial stenosis was the only factor causing a reduction in coronary flow reserve, flow reserve measured with both digital subtraction cineangiography and with the Doppler probe correlated well with the cross-sectional area at the site of obstruction, r = 0.88, SEE = 0.36 and r = 0.77, SEE = 0.45 respectively. In contrast, when other factors decreasing coronary flow reserve were present (intimal dissection, left ventricular hypertrophy, previous myocardial infarction, collaterals) measurements obtained with both techniques correlated poorly with cross-sectional area (r = 0.55, SEE = 0.57, and r = 0.59, SEE = 0.50). Flow reserve measurements obtained with digital subtraction cineangiography correlated well with the measurements obtained with the Doppler probe (r = 0.85, SEE = 0.38, and r = 0.87, SEE = 0.34), although the two approaches have methodologically nothing in common and their respective regions of interest (myocardium for the radiographic technique and intracoronary lumen for the Doppler technique) are basically different. Furthermore, the reactive hyperaemia following the final balloon inflation was related to the flow reserve measured with both the angiographic technique (r = 0.85, SEE = 0.34) and the Doppler technique (r = 0.83, SEE = 0.32) using pharmacologically induced coronary vasodilation with intracoronary papaverine. This suggests that the same quantity of coronary flow reserve that can be recruited pharmacologically can be recruited by ischaemia following a transluminal occlusion.</description>
    </item> <item>
      <title>Coronary blood flow velocity during percutaneous transluminal coronary angioplasty as a guide for assessment of the functional result (Article)</title>
      <link>http://repub.eur.nl/res/pub/4276/</link>
      <pubDate>1988-01-01T00:00:00Z</pubDate>
      <description>To investigate the clinical usefulness of intracoronary Doppler recordings during percutaneous transluminal coronary angioplasty (PTCA), the changes of intracoronary blood flow velocity during PTCA were assessed in 20 patients with single proximal coronary stenosis, using a Doppler probe end-mounted on the tip of a PTCA catheter. A mean of 4 inflations was performed in each patient. Intracoronary velocities were measured before and after each inflation and during peak reactive hyperemia after each transluminal occlusion. Quantitative analysis of the coronary stenosis was assessed before and after PTCA, and the dilatation resulted in an increase in minimal luminal cross-sectional area from 1.1 +/- 0.8 to 2.7 +/- 1.2 mm2. A gradual and significant improvement in velocities was observed after the first 3 dilatations, but in 15 of the 20 patients the resting and hyperemic velocities were not affected by the fourth dilatation. Coronary flow reserve measured during reactive hyperemia after the last dilatation with the PTCA catheter across the lesion was 1.9. This value of coronary flow reserve is compatible with the residual stenosis measured after PTCA when corrected for the presence of the Doppler balloon catheter (0.68 mm2). This application of the Doppler technique may provide a new method of on-line functional monitoring of the PTCA procedure in individual patients, but does not yet allow an accurate prediction of the change in coronary geometry brought about by PTCA.</description>
    </item> <item>
      <title>Percutaneous balloon valvuloplasty for calcific aortic stenosis. A treatment sine cure? (Article)</title>
      <link>http://repub.eur.nl/res/pub/4291/</link>
      <pubDate>1988-01-01T00:00:00Z</pubDate>
      <description>Twenty-five elderly patients with calcific aortic stenosis, 12 male (48%) and 13 female (52%), mean age 74.8 +/- 7.6 years, underwent percutaneous aortic balloon valvuloplasty between March 1986 and September 1987. Twenty-two patients (88%) were in class III-IV of the New York Heart Association, 13 (52%) had a history of previous angina and 7 (28%) of syncopal attacks. All patients had been considered either unsuitable or high-risk candidates for aortic-valve replacement because of age or associated diseases. Balloons of increasing size (area ranging from 1.3 to 3.8 cm2 during inflation) were successively passed retrogradely from the femoral artery and manually inflated to 3-7 atmospheres. Inflation duration ranged from 15 to 260 s (mean 40 s). Post-dilatation there were significant changes in left ventricular peak-systolic and end-diastolic pressures (P less than 0.00001 and P less than 0.01, respectively), mean systolic aortic transvalvular gradient (from 73 to 43 mmHg, P less than 0.000001), mean systolic aortic flow (from 176 to 208 ml s-1, P less than 0.0001) and aortic valve area (from 0.47 to 0.72 cm2, P less than 0.000001). Major complications included: in-hospital deaths of two patients (8%) admitted in cardiogenic shock; left haemiplegia (4%); transient haemianopia (8%); development of grade III aortic insufficiency (4%); and persistent complete atrioventricular block (4%). Complications at the puncture-site occurred in 7 patients (28%)--including two femoral pseudoaneurysms and the need for surgical removal of a balloon remnant after rupture in one patient. No local haemorrhagic complications were observed in the latter eight procedures, performed using a 16.5 French 100-cm long arterial introducer. At a mean follow-up of 13.0 +/- 5.0 months, an important functional improvement persisted in 14 patients (56%), no major changes in pre-valvuloplasty symptoms were observed in 3 patients (12%), while five patients (20%) required surgical treatment after a successful valvuloplasty because of recurrence of symptoms (late valve restenosis). Percutaneous aortic balloon valvuloplasty is a possible palliative therapy in elderly patients with calcific aortic stenosis. However, its inherent immediate risk, limited haemodynamic result and the possible development of valve restenosis at medium-term follow-up, suggest that the application of this technique should be limited to poor surgical candidates.</description>
    </item> <item>
      <title>Is the rate of disappearance of echo contrast from the interventricular septum a measure of left anterior descending coronary artery stenosis (Article)</title>
      <link>http://repub.eur.nl/res/pub/4292/</link>
      <pubDate>1988-01-01T00:00:00Z</pubDate>
      <description>Although myocardial contrast echo has been used recently in human studies, no study is available at the present time which relates contrast echo findings to the degree of coronary artery stenosis. The present study is the first attempt to determine whether a quantitative relationship exists between regional myocardial echo contrast disappearance rate ('washout') and the severity of coronary artery stenosis. Manual injection of sonicated iopamidol (Iopamiro 370) into the left main coronary artery with simultaneous cross-sectional echo registration provided the myocardial echo-contrast images. From the digitized images, an echo contrast time-intensity curve was constructed for the proximal basal interventricular septum (region I) and the mid-distal portion of the interventricular septum (region II). From these curves, T50 was calculated after Fourier transformation and mono-exponential curve fitting. The percentage stenosis area (%A) of the left descending coronary artery (LAD) was calculated from routine coronary arteriograms using a computer-based system. Thirty patients (22 men, 8 women; mean age 58 +/- 10 years) were included in the study. Group I (n = 7) had normal LAD, group II (n = 18) had LAD stenosis of varying degrees. Five patients were not suitable for quantitative evaluation. A curvilinear relation was found between T50 and %A. (T50 = 3.0 x e0.01%A; r = 0.78; P less than 0.05). Patients with asynergy had significantly longer T50 (8.2 +/- 2.5 s) than did patients without asynergy (4.2 +/- 1.5 s) (P less than 0.05). All patients with greater than 75% LAD %A had prolonged T50. T50 might be useful index for studying regional myocardial perfusion during cardiac catheterization.</description>
    </item> <item>
      <title>Quantitative assessment of myocardial blood flow by contrast two-dimensional echocardiography: initial clinical observations (Article)</title>
      <link>http://repub.eur.nl/res/pub/4238/</link>
      <pubDate>1987-01-01T00:00:00Z</pubDate>
      <description>Myocardial contrast two-dimensional echocardiography (MC-2DE) is a new technique to study myocardial perfusion imaging. Whether quantitative analysis of MC-2DE has any clinical significance is not known. We studied 12 patients during cardiac catheterization and coronary arteriography by MC-2DE, using sonicated iopamidol (microbubble size 12 +/- 4 micron) as the echocontrast agent. Selective intracoronary injections of 4 cc were performed into the left and right coronary artery. Two-dimensional echocardiograms were made before, during, and after injection from the apical four-chamber view. The coronary artery stenosis was calculated by automated boundary detection from the digitized cine arteriograms and expressed as percentage area stenosis (%S); also the absolute minimal luminal area (L) was calculated. From the MC-2DE video images, end-diastolic frames were chosen for digitization and videointensity measured from a region of interest at basal or midseptal level. This analysis reveals a curve of echo intensity versus time. From these curves, total curve area (A), curve duration (T), and time from peak intensity to 50% intensity decay (T50) were measured. Multiple regression analysis reveals the best correlation between %S and A (A = 52.48. e0.02%S; P less than .0001; r = 0.89). Correlations between %S, L, and T and T50, respectively, were less. Thus MC-2DE quantitative analysis shows a good agreement with anatomical size of coronary artery stenosis. These findings might have important clinical implications for future follow-up of various therapeutic procedures such as transluminal angioplasty thrombolysis.</description>
    </item> <item>
      <title>Value of the regurgitant volume to end diastolic volume ratio to predict the regression of left ventricular dimensions after valve replacement in aortic insufficiency (Article)</title>
      <link>http://repub.eur.nl/res/pub/4248/</link>
      <pubDate>1987-01-01T00:00:00Z</pubDate>
      <description>The aim of this study was to assess the value of regurgitant stroke volume (RSV) to end-diastolic volume (EDV) ratio to predict the regression of left ventricular (LV) dimensions after uncomplicated valve replacement in 34 patients with severe pure aortic insufficiency. The RSV/EDV ratio was measured by contrast ventriculography and thermodilution techniques. LV end-diastolic diameter (EDD) was measured pre- and postoperatively by M-mode echocardiography (at a median interval of 3.3 years after valve replacement). LV/EDD decreased from 74 +/- 8 mm to 54 +/- 11 mm (P less than 0.001). Eleven patients had a persistent postoperative LV enlargement (median EDD 65 mm, range 56-100 mm) while, in 23 patients, EDD became normal (median 49 mm, range 40-55 mm). During follow-up, one patient with LV enlargement died of congestive heart failure. Preoperative RSV/EDV ratio was significantly higher in patients with normal postoperative EDD as compared to those with persistent LV enlargement (0.32 +/- 0.06 vs. 0.24 +/- 0.07, P less than 0.005). The best cutoff point of RSV/EDV to predict the normalization of LV dimensions was 0.28. Postoperative EDD remained abnormal in eight out of 16 patients (50%) with RSV/EDV ratio less than 0.29, while it remained enlarged in only three out of 18 patients (17%) with a preoperative RV/EDV ratio greater than 0.28. The other usual preoperative catheterization and echocardiographic variables were equally or less predictive than RSV/EDV ratio. In conclusion, despite the limitations due to the use of different techniques, we confirmed that the RSV/EDV ratio is a potentially useful variable for the assessment of the proper timing of valve replacement in patients with severe isolated aortic insufficiency.</description>
    </item> <item>
      <title>An elusive persistent left superior vena cava draining into left atrium (Article)</title>
      <link>http://repub.eur.nl/res/pub/4180/</link>
      <pubDate>1986-01-01T00:00:00Z</pubDate>
      <description>A case report of a persistent left superior vena cava draining into left atrium with a fibromuscular left ventricular outflow tract obstruction and a small atrial septal defect. The anomalous vessel escaped detection during two right and left heart catheterizations from the right arm and open heart surgery. It was an incidental finding during cardiac catheterization from the left arm and the anatomy was confirmed by contrast echocardiography.</description>
    </item> <item>
      <title>Revascularization as a means of reducing sudden death (Article)</title>
      <link>http://repub.eur.nl/res/pub/4210/</link>
      <pubDate>1986-01-01T00:00:00Z</pubDate>
      <description>From this brief overview the arguments have become clear why further studies are needed to verify that the problem of unnecessary sudden cardiac death can best be tackled by a strategy aimed at early and complete revascularization. Whether such a strategy begins with intravenous injection of rt-PA at home or requires subsequent intracoronary manipulation when obstruction persists, whether by thrombolysis with other agents, PTCA or bypass surgery, is in itself a moot point. The main aim should be to offer this strategy as the best chance to reduce the unnecessary sudden death rate which presently accounts for between 25 and 50% of all cardiac deaths. This approach deserves consideration particularly since earlier approaches employing cardioprotective efforts by beta blockade or by anti arrhythmic agents have patently shown that they cannot tackle the problem in a convincing manner.</description>
    </item> <item>
      <title>Assessment for prognosis during and after myocardial infarction. A plea for a stratified approach (Article)</title>
      <link>http://repub.eur.nl/res/pub/4211/</link>
      <pubDate>1986-01-01T00:00:00Z</pubDate>
      <description>Right after the first signs and symptoms of acute myocardial infarctions the prognosis is determined by the interventions which are carried out at that time. Preservation of as much myocardial tissue is the key element. Early deobstruction and reperfusion of the myocardium at jeopardy can lead to limitation of the ultimate infarct size, improved ventricular function and a halving of the 1-year mortality. Early supportive therapy with beta-blockade and calcium antagonists may enhance this effect. Data in 533 patients randomized to either a reperfusion strategy or to conventional therapy, combined with those from the recent literature on thrombolysis and early beta-blockade, provide the basis for this point of view. Once infarction is unavoidable and in the process of completion, probably 3-4 h after onset of symptoms, only supportive therapy is recommended, which will hardly change the outcome except for interventions during clinical care such as defibrillation. In 351 other survivors of myocardial infarction the value of clinical variables, a symptom-limited bicycle stress test at discharge, radionuclide ventriculography and 24-hour ambulatory electrocardiogram was compared in predicting 1-year survival. A history of previous myocardial infarction and heart failure during the current episode proved to be the strongest clinical predictors of death. Similarly, a low ejection fraction (less than 40%) and an insufficient blood pressure rise during stress testing (less than 30 mm Hg) identified a high risk group. Stress-test-induced angina and ST depression as well as ventricular arrhythmias from 24-hour electrocardiography were less good as predictors. In these patients treatment should be individualized and may require arteriography. Patients eligible for and completing a normal bicycle stress test after myocardial infarction proved to be a low risk group, which may constitute 65% of the total, seen in tertiary referral centers and even more in community hospitals. They neither require therapy nor further investigation. A subgroup with an intermediate risk can be identified when clinical variables, stress testing and/or resting radionuclide ventriculography are abnormal. This group requires 'tailored' therapy. Therefore, after infarction recovery, we recommend a pre-discharge stress test routinely to complement the clinical evaluation, since it also provides information on physical capacity, the indication of arrhythmias and the presence of myocardial ischemia. Thus, optimal management of acute myocardial infarction requires a stratified approach, which does not require expensive testing procedures.</description>
    </item> <item>
      <title>Zien wat je niet ziet (Inaugural Lecture)</title>
      <link>http://repub.eur.nl/res/pub/26803/</link>
      <pubDate>1984-10-24T00:00:00Z</pubDate>
      <description>Rede, uitgesproken bij de aanvaarding van het ambt van gewoon hoogleraar
in de klinische echocardiografie aan de faculteit der geneeskunde
van de Erasmus Universiteit te Rotterdam, op woensdag 24 oktober
1984</description>
    </item> <item>
      <title>Contrast echocardiographic shunts may persist after atrial septal defect repair (Article)</title>
      <link>http://repub.eur.nl/res/pub/4083/</link>
      <pubDate>1983-01-01T00:00:00Z</pubDate>
      <description>We performed contrast echocardiography on 19 subjects who were asymptomatic in the postoperative period after surgical repair of atrial septal defects. Eighteen of these subjects had adequate right heart echocardiographic contrast to assess the presence or absence of right-to-left shunting. Multiple M-mode and two-dimensional echocardiographic views were studied during several contrast injections with and without the Valsalva manoeuvre. Six patients had postoperative shunts and 12 patients had no postoperative shunts. The age of the six patients with postoperative shunts was 26 +/- 10 years (mean +/- s.d.) and that of the 12 patients without postoperative shunts was 39 +/- 14 years. Four out of six of the postoperative shunt group were males and of these three had patch repairs compared with two males out of 12 with patch repair in the no shunt group. There were no definite differences between the two groups in the following variables: type of atrial septal defect (primum v. secundum), preoperative shunt size, pre-operative peak right ventricular pressure, pre-operative New York Heart Association functional class, pre- or postoperative right ventricular or left ventricular dimensions, aortic and left atrial dimensions. Four of the six patients with postoperative contrast echo shunting underwent cardiac catheterization, showing no significant step-up in oxygen saturation in three, and a significant shunt in one patient who had patch dehiscence at re-operation. We conclude that right-to-left shunts as demonstrated by contrast echocardiography are common in the late postoperative period after atrial septal defect repair. They need not indicate unsuccessful repair or a haemodynamically important residual shunt.</description>
    </item> <item>
      <title>Echocardiography in chronic aortic insufficiency. Is valve replacement too late when left ventricular end-systolic dimension reaches 55 mm? (Article)</title>
      <link>http://repub.eur.nl/res/pub/4085/</link>
      <pubDate>1983-01-01T00:00:00Z</pubDate>
      <description>To determine whether a ventricular (LV) end-systolic dimension (ESD) greater than or equal to 55 mm and LV left fractional shortening less than 25% are risk factors for aortic valve replacement (AVR) in patients with aortic insufficiency, we analyzed the clinical course and M-mode echocardiograms in 47 consecutive patients who underwent AVR for isolated symptomatic AI. Group 1 patients (n = 27) had a preoperative ESD less than 55 mm (mean 44 mm, range 30-52 mm) and group 2 patients (n = 20) had a preoperative ESD greater than or equal to 55 mm (mean 62 mm, range 55-85 mm). One patient in group 1 and 10 patients in group 2 had left ventricular fractional shortening less than 25%. There were no perioperative or postoperative deaths during an average follow-up of 41 months (range 6-76 months). Five patients had perioperative myocardial infarctions (MIs), three in group 1 and two in group 2. Since myocardial protection with cold potassium cardioplegia was instituted, no patient has suffered a perioperative MI. The average preoperative New York Heart Association functional classification was 2.3 (group 1) and 2.6 (group 2). Postoperatively, it was 1.2 in group 1 and 1.1 in group 2. Thirty-three patients (20 in group 1 and 13 in group 2) had echocardiograms at least 1 year after AVR. Of these, LV-end diastolic dimension decreased fro 67 +/- 6 to 53 +/- 6 mm (mean +/- SD) in group 1 (p less than 0.001) and from 79 +/- 3 to 55 +/- 6 mm in group 2 (p less than 0.001). The LVESD also decreased, but this is difficult to interpret because of frequent postoperative abnormal interventricular septal motion. The LV cross-sectional area, an index of LV mass, decreased in group 1 from 25 +/- 5 to 20 +/- 5 cm2 (p lss than 0.001) and in group 2 from 32 +/- 9 to 20 +/- 5 cm2 (p less than 0.001). Postoperative end-diastolic dimension and cross-sectional area were not significantly different between the two groups. We concluded that in aortic insufficiency, a preoperative ESD greater than or equal to 55 mm does not preclude successful AVR, as judged by long-term survival, symptomatic relief, and normalization of LV dimensions assessed by echocardiography.</description>
    </item> <item>
      <title>Extent of hypertrophy in hypertrophic cardiomyopathy: two-dimensional echocardiographic and angiographic correlation (Article)</title>
      <link>http://repub.eur.nl/res/pub/4106/</link>
      <pubDate>1983-01-01T00:00:00Z</pubDate>
      <description>Since the first anatomical and functional descriptions of hypertrophic cardiomyopathy (HCM) there have been convincing attempts at better understanding and definition of the controversial aspects of this complex disease.</description>
    </item> <item>
      <title>Effects of short-term administration of verapamil on left ventricular relaxation and filling dynamics measured by a combined hemodynamic-ultrasonic technique in patients with hypertrophic cardiomyopathy (Article)</title>
      <link>http://repub.eur.nl/res/pub/4107/</link>
      <pubDate>1983-01-01T00:00:00Z</pubDate>
      <description>The effects of short-term administration of verapamil on left ventricular isovolumetric relaxation and early and late diastolic filling dynamics were studied in 10 patients with hypertrophic cardiomyopathy by a combined hemodynamic-ultrasonic technique. Left ventricular pressures (recorded with high-fidelity micromanometers) were determined simultaneously with M mode echocardiography. After 10 mg of verapamil was given intravenously (2 mg/min), left ventricular contractility and systolic pressure dropped significantly (p less than .05). Left ventricular dP/dt fell from 1947 +/- 544 to 1489 +/- 334 mm Hg/sec, maximal velocity of the contractile element at zero load fell from 50 +/- 17 to 42 +/- 15 1/sec, peak velocity contraction of the contractile element fell from 37 +/- 10 1/sec to 29 +/- 10 1/sec (p less than .05), and left ventricular systolic pressure fell from 149 +/- 30 to 127 +/- 22 mm Hg. Left ventricular negative dP/dt increased from 1770 +/- 479 to 1477 +/- 377 mm Hg/sec (p less than .05), and the time constant of isovolumetric pressure decay was prolonged from 48 +/- 9 to 64 +/- 15 msec (p less than .05). Left ventricular end-diastolic pressure rose from 21 +/- 7 to 23 +/- 6 mm Hg (p less than .05). The time constant of isovolumetric pressure decay was calculated in three different ways, but none of these measurements was influenced by verapamil. Time of isovolumetric relaxation, duration of rapid ventricular filling, and peak rate of left ventricular lengthening were not significantly influenced by verapamil and remained highly abnormal. In contrast, peak rate of left ventricular posterior wall thinning declined further after verapamil from 2.9 +/- 1.2 to 2.4 +/- 1.4 1/sec (p less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)</description>
    </item> <item>
      <title>Videodensitometric processing of contrast two-dimensional echocardiographic data (Article)</title>
      <link>http://repub.eur.nl/res/pub/4076/</link>
      <pubDate>1982-01-01T00:00:00Z</pubDate>
      <description>We developed a computer program to analyze videodensity changes due to contrast appearance within a given operator-designated rectangle using two-dimensional echocardiograms previously recorded on videotape. Videodensity curves have been obtained from two-dimensional echocardiographic recordings in 14 patients after a total of 32 injections of 5% dextrose solution into the left ventricle during cardiac catheterization. The resulting videodensity vs time curves have some characteristics of indicator-dilution curves. The decay phase of these curves is largely mono-exponential. Potential clinical applications of this technique in measurement of ejection fraction, cardiac output and shunt quantification are discussed, as well as some potential limitations.</description>
    </item> <item>
      <title>Cardiac catheterization under echocardiographic control in a pregnant woman (Article)</title>
      <link>http://repub.eur.nl/res/pub/4035/</link>
      <pubDate>1981-01-01T00:00:00Z</pubDate>
      <description>A 22 year old woman had signs of rheumatic mitral and aortic valve disease early in pregnancy. Cardiac catheterization was performed during her third month of pregnancy under two-dimensional echocardiographic control without the use of ionizing radiation. Severe mitral stenosis with mild aortic stenosis was found. Five cubic centimeters of 5 percent dextrose in water were injected by hand to obtain left ventriculograms and supravalvular aortograms of sufficient quality to diagnose valvular regurgitation. The use of "echo-catheterization" may have significant advantages in selected clinical situations.</description>
    </item> <item>
      <title>Diagnosis of tricuspid regurgitation by contrast echocardiography (Article)</title>
      <link>http://repub.eur.nl/res/pub/4040/</link>
      <pubDate>1981-01-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Intravenous carbon dioxide as an echocardiographic contrast agent (Article)</title>
      <link>http://repub.eur.nl/res/pub/4044/</link>
      <pubDate>1981-01-01T00:00:00Z</pubDate>
      <description>Intravenous carbon dioxide (CO2) was employed to cause echocardiographic contrast in 40 patients. One to 3 cc of medically pure CO2 were agitated with 5 to 8 cc of 5% dextrose in water and rapidly injected into an upper extremity vein. Contrast was obtained in all patients. In 33 patients contrast density from 5% dextrose was compared with that from 5% dextrose-CO2 injections. Six of these patients had no contrast on the initial 5% dextrose injection and definite contrast with the subsequent injection containing CO2. Of the 33, 12 patients had initial contrast with 5% dextrose injections and greater contrast density when CO2 was added; 15 showed no definite difference; and none had less contrast with intravenous CO2-5% dextrose than with 5% dextrose alone. Intravenous CO2-5% dextrose is a useful method of increasing contrast in those patients who fail to demonstrate echocardiographic contrast when routine techniques are employed. It is also safe, provided precautions emphasized in this paper are observed.</description>
    </item> <item>
      <title>Transmission of ultrasonic contrast through the lungs (Article)</title>
      <link>http://repub.eur.nl/res/pub/4050/</link>
      <pubDate>1981-01-01T00:00:00Z</pubDate>
      <description>--</description>
    </item> <item>
      <title>Ultrasonic two-dimensional imaging of the heart with multiscan (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/31430/</link>
      <pubDate>1980-02-06T00:00:00Z</pubDate>
      <description>The introduction of the prototype of an ultrasonic linear
array scanner in 1971, confronted us with a type of diagnostic
information which was different from conventional
cardiac imaging techniques. With the use of ultrasound,
cardiac structures were now displayed in a direct and
positive manner rather than as shadows or negative
impressions in contrast media as seen with X-ray and
angiocardiographic techniques. Imaging in multiple new
planes through the heart now became possible. These planes
were difficult or impossible to visualize With other
techniques. Therefore hardly any knowledge about the
anatomic information in these images existed. The major
aim of this thesis is to present the implementation into
the clinical practice of cardiology of the linear array
system which was developed at the Thoraxcenter in
Rotterdam</description>
    </item> <item>
      <title>Pulmonary wedge injections yielding left-sided echocardiographic contrast (Article)</title>
      <link>http://repub.eur.nl/res/pub/4025/</link>
      <pubDate>1980-01-01T00:00:00Z</pubDate>
      <description>Ultrasound contrast on the left side of the heart without the need for left heart catheterisation was achieved by hand injections of 8 to 10 ml 5 per cent dextrose solution through a catheter in the pulmonary wedge position. Injections were performed in 18 patients undergoing routine cardiac catheterisation and M-mode or two-dimensional echocardiography was used. An adequate wedge position was attained in 17 of the 18 patients. Nine had injections through Cournand catheters, three through Swan-Ganz catheters, and five through both. In 11 of these 17 patients left atrial or left ventricular echocardiographic contrast was seen immediately after wedge injection. Two patients showed diminished or absent contrast on later injections from the same position. Better results were obtained with the Cournand catheter (11/15 positive) than with the Swan-Ganz (1/8 positive) catheter. Pulmonary artery injections proximal to the wedge position did not cause left-sided contrast. No complications were observed. The safety of this method remains to be determined.</description>
    </item> <item>
      <title>Évaluation clinique d'un appareil d'échocardiographie bidimensionnelle miniaturisé: le stéthoscope ultrasonique (Article)</title>
      <link>http://repub.eur.nl/res/pub/4011/</link>
      <pubDate>1979-01-01T00:00:00Z</pubDate>
      <description>An autonomous, miniaturised, semi-automatic linear-array system of real time imaging is described. This device was used for over one year in the coronary care unit, in the out-patient clinic and in the ward at the patient's bedside. Comparison with echocardiographic measurements obtained at M-mode echocardiography showed a slight tendency towards over estimation, especially of the dimensions of the left ventricle. The possibility of obtaining a rapid dynamic scan of the cardiac structures with the aid of an ultrasonic stethoscope will undoubtedly have the same stimulating effect on the development of miniaturised systems of real time imaging as the perfectioning of linear array system by Bom in 1971 had on two dimensional echocardiography.</description>
    </item> <item>
      <title>Intracardiac right-to-left shunts demonstrated by two-dimensional echocardiography after peripheral vein injection (Article)</title>
      <link>http://repub.eur.nl/res/pub/4013/</link>
      <pubDate>1979-01-01T00:00:00Z</pubDate>
      <description>--</description>
    </item> <item>
      <title>Échocardiologie de contraste en deux dimensions et en temps réel. 1. Techniques ultrasoniques (Article)</title>
      <link>http://repub.eur.nl/res/pub/4001/</link>
      <pubDate>1978-01-01T00:00:00Z</pubDate>
      <description>An aqueous solution (5% glucose) injected rapidly into a peripheral vein modifies the acoustic homogeneity of the blood not only at the periphery, but also within the cavities of the heart. This ultrasonic contrast technique has taken a new lease of life thanks of two-dimensional echocardiology in real time, which allows the blood to be visualised as it moves. A description is given of the current two-dimensional real time transducers, and the dynamically focal multiscan which has been developed in our laboratories. An analysis is made of the chosen ultrasonic contrast medium (glucose water), of the site and mode of injection, of the recording technique and of the various echocardiological views. Finally, a discussion highlights the limitations of single crystal echocardiography, and the advantages of the two-dimensional technique in real time.</description>
    </item> <item>
      <title>Echocardiologie de contraste en deux dimensions et en temps réel. 2 Applications cliniques (Article)</title>
      <link>http://repub.eur.nl/res/pub/4002/</link>
      <pubDate>1978-01-01T00:00:00Z</pubDate>
      <description>The anatomical and functional abnormalities which are the basis of septal defects and valvular incompetence can be visualised directly by two-dimensional contrast echocardiology. Although right-left shunts at atrial or ventricular level can easily be discovered and visualised after injection peripherally, the same is not true of left-right ventricular shunts; these are not detectable. As for left-right shunts (as demonstrated by oxymetry) at the atrial level, these are in a separate category; the passage of ultrasonic contrast medium from right to left is inconstant. This technique also allows the study of abnormal blood flow: tricuspid incompetence, turbulence caused by prosthetic valves, etc.</description>
    </item>
  </channel>
</rss>